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The regeneration of whole osteochondral constructs with a physiological structure 
has been a significant issue, both clinically and academically. An optimal method that 
can regenerate multilayered tissue structure is needed.  In this study, several 
co-culture methods were designed and investigated their effectiveness for generating 
the osteochondral interface and multilayered structure in vitro. Rabbit bone marrow 
stromal cells (BMSCs) and silk/RADA (Ac-RADARADARADARADA-CONH2) 
peptide scaffold were used in this study. The study was grouped into four stages: (i) 
design and development of the scaffold and osteochondral interface formation by 
2D-3D co-culture system, (ii) development 3D-3D co-culture system, (iii) the 
development of static co-culture wells, and (iv) three-chamber bioreactor. 
The first stage involved the design and fabrication of the silk/RADA scaffold. 
Then the 2D-3D chondrogenic BMSCs/osteoblasts co-culture model was designed. 
The 2D-3D co-culture system was set up by first independently culturing 
chondrogenic rBMSCs on a scaffold and osteoblasts in cell culture plates, and 
subsequently placed in contact and co-cultured. By co-culture, specific regulatory 
stimulations from osteoblasts in the 2D-3D interface co-culture system could induce 




The second stage then involved the design and establishment of 3D-3D 
osteogenic/chondrogenic BMSCs co-culture model.  BMSCs seeded scaffolds were 
firstly cultured independently in osteogenic and chondrogenic stimulation medium. 
Then these two differentiated pieces were stuck together by using RADA 
self-assembled peptide and subsequently co-cultured. Results revealed that osteogenic 
and chondrogenic BMSCs affected each other in this co-culture system and induced 
the formation of the osteochondral interface. Moreover, this system provided a 
possible approach for generating multilayered osteochondral constructs. 
The third stage involved the design of two-chambered co-culture well for the 
generation of multilayered osteochondral constructs in-vitro. This specially designed 
two-chambered well could simultaneously provide osteogenic and chondrogenic 
stimulations to the cells located in different regions of the scaffold. This co-culture 
approach could successfully provide osteogenic and chondrogenic stimulation to 
BMSCs located on different layers within a single scaffold, resulting in the formation 
of multilayered osteochondral constructs containing, cartilage-like and subchondral 
bone-like tissue, as well as the intermediate osteochondral interface. 
The fourth stage involved an analysis of the effectiveness by using hypertrophic 
chondrogenic medium for BMSCs hypertrophic chondrogenic differentiation. This 
medium was proved that it could induce the differentiation of hypertrophic 
chondrocytes. Subsequently, a bioreactor that could provide 3 kinds of medium 
(chondrogenic, osteogenic and hypertrophic chondrogenic) was fabricated. This 
bioreactor could change medium automatically, which reduce the unwanted medium 
 ix 
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1.1. Background and Significance 
Osteochondral constructs are defined as tissues that are composed primarily of 
bone and cartilage, specially the articular cartilage that is found in all joints in our 
bodies. The osteochondral tissue consists of multiple tissue layers with different 
structures, such as cartilage layer, osteochondral interface, subchondral bone layer and 
bone [1, 2]. Osteochondral tissues provide important connective and articulating 
functions in our bodies [3, 4]. Of the various osteochondral tissues, the knee joint 
osteochondral tissue is one of the most highly stressed structures in the body. It plays 
a significant role in maintaining physiological knee mechanics and joint stability [5]. 
Although osteochondral tissues function optimally under normal physiological 
compression and friction, it is one of the most frequently injured and damaged 
structures [2, 6, 7].  
Osteochondral tissues include three main layers: cartilage, bone and the 
osteochondral interface. Cartilage, especially the hyaline cartilage in osteochondral 
tissue is an avascular connective tissue that has smooth surfaces for joint articulation 
and is found at all joints [8]. Subchondral bone is a complex tissue which is lined 
 2 
 
adjacent to cartilage and designed to provide mechanical support [9]. The 
osteochondral interface describes the calcified cartilage where the cartilage and the 
underlying subchondral bone meet. This intermediate layer serves the functions of 
connecting cartilage and subchondral bone, transmission of mechanical strength and 
reduction of stress concentrations as well as better integration with the underlying 
bone [10].  
Osteochondral defects, caused by traumatic injuries, osteochondritis dissecans 
and chondromalacia, usually in knee, are often associated with mechanical instability 
of the joint [11]. Sometimes, osteochondral defects are derived by superficial 
cartilaginous layer defects. Damage in cartilage surface often causes degeneration to 
the subchondral region [12]. There are many possibilities that can cause cartilage 
defects, such as a traumatic sport-accident, previous knee injuries or wear and tear 
over time [6].  Immobilization for a long time can also result in cartilage damage [6]. 
However, human cartilage’s self-repairing ability is limited. This is because the ability 
of hyaline cartilage to respond to injury is poor. Once the cartilage damage has 
occurred, an irreversible degenerative process can occur and reach the bone region to 
form the osteochondral complete defects [2, 13]. Moreover, it may induce 
osteoarthritic degenerative changes with time [14]. In the US alone, osteoarthritis 
affects around 20% of the population. One-third of patients experience functional 
limitations and need surgical treatments. The total direct cost of osteoarthritis is 
estimated at US$28.6 billion dollars a year [15]. 
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 Due to the poor self-regeneration ability of osteochondral defects, surgical 
treatment is always needed to treat the serious defects. Autograft is one of the most 
commonly used methods, such as Mosaicplasty and Osteochondral Autolograft. In 
these methods, osteochondral plugs are harvested from a non-load bearing area and 
transplanted into the defect site [16]. However, it faces some drawbacks, such as 
limited donors and inability to treat large defect [17]. Another method is microfracture. 
Surgeons drill holes in the defect site and allow the bone marrow cells to migrate to 
the defect site to regenerate the cartilage [18, 19]. Most recently, carticels, a procedure 
that consist of injecting patients’ chondrocytes in the defect part and then covering the 
defect with periosteal flap are being used. However, this method do not have 
inter-patient consistency, moreover, the surgical procedure is complex and hard to 
handle [20, 21]. Allograft transplantation of osteochondral grafts methods has some 
clinical successful cases, but it has the same issues limited donors and the possibility 
of infection  [22]. Last but not least, total joint replacement which uses artificial 
materials, such as metal and polymer [23]. All these conventional therapies are 
deemed limit in the treatment of osteochondral defects, thus other novel strategies are 
needed to solve these problems.  
Tissue engineering provides a potential solution for these limitations. The goal of 
osteochondral tissue engineering is to generate neotissue from autologous/allogeneous 
cells grown on biocompatible/biodegradable scaffolds and raise the hope that tissue 
engineered grafts can interact with their environment while providing structural and 
mechanical functionality; moreover the regenerated grafts should integrate with the 
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host sites. Firstly, a unique geometry of 3D- bioabsorbable porous scaffold should be 
designed for patients [14, 24, 25]. Then the scaffold should be combined with patients’ 
own cells [24]. The specially designed scaffolds can provide a proper cell living 
environment for cells, including chemical composition environment and mechanical 
support [14, 26]. The control culture should induce the osteochondral tissue grafts 
formation [27]. However, presently, several limitations in this field still need to be 
solved. One of the issues is that the traditional approaches are not effective to produce 
the regeneration for both bone and cartilage concurrently. Usually, the engineered 
constructs do not have osteochondral interface regions [2, 24, 28, 29]. Thus, to 
achieve the goal of regenerating the complete osteochondral tissue, the way of 
forming the interface and layered osteochondral structure is one of the main 
challenges in this field.  
Three main aspects, including scaffolds, cells and stimulation factors form the 
tissue engineering approach. For new osteochondral tissue generation, scaffolds have 
to provide structural template for new tissue development [30]. In addition, for many 
tissue regenerations, a comparable mechanical strength that mimics the natural tissues 
and speed of degradation, which allows both new tissue regeneration and progressive 
load transfer to new tissue without causing rupture of the construct, are needed 
[30-32]. Moreover, the scaffold should have enough porosity and interconnectivity for 
cell migration, extracellular matrix (ECM) deposition and the exchanging of nutrition 
and waste [33]. A variety of scaffold materials have been explored for osteochondral 
tissue regeneration [14], with the commonly used ones ranging from synthetic 
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polymer based biomaterials to natural materials [34].  
    Silk, a natural fibrous protein derived from Bombyx mori silk worms, 
possesses remarkable mechanical properties and a slow degradation rate that is 
suitable to support the healing skeleton tissue over a period of 6 to 12 months [35, 36]. 
Its properties of biocompatibility, morphologic flexibility, environmental stability and 
the ability for functionalization via amino acid side chain modification to immobilize 
functional groups, make it useful as a scaffolding biomaterial [36-38]. Silk-based 
scaffolds in the form of porous sponges have already been investigated for bone and 
cartilage tissue regeneration.  However, microfibrous scaffolds often allow only 
limited cell attachment and result in non-homogeneous cell distribution within the 
scaffold [39]. Moreover, silk microfibers (diameter: 10-25 µm) and cells (diameter: 
5-30 µm) are of similar dimensions, therefore seeded cells essentially encounter a 2D 
environment within the scaffolds, which fail to biomimic the 3D environment 
presented by collagen nanofibrils in the natural extracellular matrix. Especially, for 
cartilage tissue engineering, smaller pore size are generally required, which has been 
suggested that pore size around 20 µm is suitable [40]. To achieve to solve these 
problems, some other structured materials are needed to be combined with silk sponge 
scaffold in osteochondral tissue regeneration.  
Self-assembling peptides have been recently used to fabricate nanofibrous 
scaffolds in tissue engineering research. These self-assembled nanofibrous scaffolds 
have more than 99% water content and possess excellent biocompatibility. RADA, the 
most common self-assembling peptide used, forms β-sheet structures that are stable 
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across a wide range of temperature and pH. The generated nanofibres biomimic the 
natural ECM and enhance the attachment, growth and differentiation of a variety of 
cells [41-43]. Scaffolds made of self-assembled peptide nanofibers have also been 
used for delivering growth factors and cells into scaffolds [44]. However, such 
nanofibers alone lack desirable mechanical properties and often required to be 
combined with other macrofibrous scaffolds to generate hybrid scaffolds that could be 
used to engineer mechanically strong tissues such as bones [45]. For silk sponge 
scaffold, the pore size of the sponge structure was still too large (100 μm) to create a 
real 3D environment for cell attachment and proliferation. However, a combination of 
such silk-based scaffolds with self-assembled peptide nanofibers could help in 
creating a scaffold system possessing a submicron-sized silk sponge, and nanofibrous 
peptide fibers, which could satisfy multilayered tissue generation requirement for 
cartilage, interface and subchondral bone.   
    Choosing the proper cell lines is also the key to the success of osteochondral 
tissue engineering approach. Several types of cells that have been used for 
engineering osteochondral tissue generation includes both differentiated cells, like 
chondrocytes from articular cartilage and precursor cells like bone marrow stromal 
cells (BMSCs) [3, 13, 24, 46]. Using articular cartilage derived chondrocytes implies 
that one has to harvest cells from a healthy tissue and generate a new one. BMSCs, on 
the other hand, can be obtained from bone marrow and there is no need to make a 
defect on the healthy cartilage. Such cells also lack immunogenicity, which makes 
them an ideal choice for use in allogenic implants [47, 48]. When BMSCs are used to 
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regenerate a new tissue, biological signals to encourage proliferation and 
differentiation of these seeded precursor cells into targets cell are needed [49, 50]. 
Specific growth and differentiation factors such as basic TGF-β and IGF for cartilage 
part, BMP and vitamin D for subchondral bone part, which have been shown to 
improve cartilage and subchondrol bone cell proliferation and matrix formation, both 
in vitro and in vivo [49, 51, 52].  
For the complex osteochondral tissue engineering, the regeneration of the 
osteochondral interface is considered a challenge in both research and clinic contexts. 
Co-culture method provides a possible solution to induce the formation of interface 
[29, 53]. Moreover, to achieve the requirement for multilayered osteochondral tissue 
generation, special co-culture system should be designed, which can be used to 
provide an optimal co-culture environment or layered stimulation factors providing 
environment.  
  
1.2. Objectives and research program 
The issues of conventional medical therapies to treat osteochondral defects raise 
the need to search for innovative solutions. Tissue engineering is one of the potential 
choices. The development of stem cell research and biomaterial contributes to achieve 
the mission. This study is aimed at developing co-culture models that use silk fibroin 
sponge and RADA self-assembled peptide hybrid scaffolds with rabbit BMSCs to 
generate osteochondral interface and the multilayered osteochondral tissue in vitro. 
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The specific aims thus derived are four stages:  
 
1.2.1. Stage 1: 
1.2.1.1. Design and development of the silk/peptide hybrid scaffolds 
   To design and fabricate silk/RADA peptide hybrid scaffolds to provide suitable 
living environment for both chondrogenic differentiation and osteogenic 
differentiation.  
 
1.2.1.2. Design and development of a 2D-3D co-culture model for osteochondral 
interface generation in vitro 
To study the influence of the formation of osteochondral interface by 
co-culturing method, a special 2D-3D interface co-culture model is designed. The 
2D-3D interface co-culture system that uses rabbit BMSCs and rabbit osteoblasts is 
set up. Chondrogenic rBMSCs on the scaffold (3D) and osteoblasts in well plates (2D) 
are first cultured independently. The rBMSCs seeded scaffold is then placed onto the 
osteoblast layer for the 2D-3D interface co-culture, with physical contact between the 
osteoblasts and rBMSCs at the lower surface of scaffold for co-culture.  
Hypothesis 1: Chondrogenic BMSCs in hybrid scaffolds co-cultured with osteoblasts 
would enable transmission of factors from osteogenic cells to chondrogenic BMSCs 





1.2.2. Stage 2: Development of a 3D-3D co-culture model for osteochondral 
interface and multilayered constructs generation in vitro   
    To study the influence of the formation of osteochondral interface and 
multilayered constructs, a 3D-3D co-culture model (cells seeded on two pieces of 3D 
scaffolds and adhered together) based on the cell-cell interactions between 
chondrogenic and osteogenic BMSCs is designed.   
Hypothesis 2: By co-culturing chondrogenic and osteogenic differentiated progenies, 
a whole osteochondral construct with osteochondral interface could be generated in 
vitro.  
 
1.2.3. Stage 3: Design and fabrication an appropriate co-culture system and use it 
in osteochondral tissue engineering 
To generate a whole osteochondral construct by using a static two-chambered 
co-culture well that could simultaneously provide osteogenic and chondrogenic 
chemical stimulations to cells present on different regions of a single scaffold.  
Hypothesis 3: A whole osteochondral with cartilage layer, interface and subchondrol 
bone layer can be generated by using BMSCs only and one step culturing method in 




1.2.4. Stage 4: Design and fabricate a co-culture bioreactor and the effectiveness 
of hypertrophic chondrogenic stimulation medium  
To design and set up a bioreactor that can provide 3 kinds of flowing mediums to 
stimulate BMSCs located on different layers of a single scaffold to form 
osteochondral multilayered construct.  
Hypothesis 4: A whole osteochondral with cartilage layer, interface and subchondral 
bone layer can be generated by using BMSCs only in this bioreactor system. 
 
1.3. Scope of Thesis 
This thesis composes of seven chapters and is organized as follows: 
Chapter 1 gives an introduction of the research background, objectives and scope. 
Chapter 2 will be a literature review on the anatomy and functions of the articular 
cartilage and osteochondral tissue. The structural characteristics, cell types, 
morphology and biochemical constituents of the tissue will be also presented. In 
addition, osteochondral defects and current treatment modalities will be presented 
with emphasis given on motivation towards the tissue engineering approach and 
recent progress in this field. Last but not least, the specific factors in osteochondral 
tissue engineering will be reviewed in detail. 
Chapter 3 will first present the design and fabrication of the silk/RADA scaffold. 
Then the 2D-3D chondrogenic BMSCs/osteoblasts co-culture model will be presented. 
Details of the establishment of the co-culture model and the formation of 
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osteochondral interface will also be shown in this chapter.  
Chapter 4 will focus the design and establishment of 3D-3D 
osteogenic/chondrogenic BMSCs co-culture model. The results of osteochondral 
interface and multilayered constructs formation will continue to be analyzed in this 
chapter.  
Chapter 5 will report the design and fabrication of the static co-culture wells. 
Moreover, by using this co-culture well, the formation of multilayered structure 
results will also be presented subsequently.  
Chapter 6 will provide an analysis of the effectiveness by using hypertrophic 
chondrogenic medium for BMSCs hypertrophic chondrogenic differentiation. 
Subsequently, a bioreactor that can provide 3 kinds of medium will be fabricated. 
Validity of inducing osteochondral tissue generation of this novel approach will also 
be presented and discussed, followed by assessing its feasibility for other multilayered 
tissue engineering application. 
Chapter 7 will provide a conclusion of this study as well as some recommendations 



















In this chapter, a literature review on the anatomy and functions of the articular 
cartilage and osteochondral tissue will be presented. The structural characteristics, cell 
types, morphology and biochemical constituents of the tissue will be also presented. 
In addition, osteochondral defects and current treatment modalities will be presented 
with emphasis given on motivation towards the tissue engineering approach and 
recent progress in this field. Last but not least, the specific factors in osteochondral 
tissue engineering will be reviewed in detail. 
 
2.1. Introduction 
To achieve better regeneration of the osteochondral tissue, it is important and 
necessary to understand the anatomy and composition of the tissue. In particular, its 
multilayered structure that includes different types of cells and constituents of ECM is 
the key to design this whole project. Moreover, the osteochondral tissues in the knee 
bear high compression or friction during joint motion and experience high 
possibilities of injuries that cause defects. Thus, various defects situations and current 
treatment methods will be presented and compared. Subsequently, the tissue 
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engineering approaches will be compared with tradition methods to highlight its 
potential and superiority. The main factors of osteochondral tissue engineering 
approaches will be reviewed in this chapter, which include the cell source, scaffold 
materials and architecture, stimulation factors, and co-culture technique.  
 
2.2. Osteochondral tissue Anatomy and Bioproperties 
The osteochondral tissue is located in the synovial joints, such as knee, hip, 
shoulder and elbow. It is a multilayered tissue that is made up of  surface articular 
cartilage, calcified interface and underling bone [54]. Articular Cartilage is a special 
form of hyaline cartilage that is developed from mesenchymal cells, and is subjected 
to compression, shear and hydrostatic pressure at the joint [55]. The tissue provides 
smooth gliding surface through layers’ boundary. The cartilage-forming cells, 
chondroblasts, begin to secrete the components of the extracellular matrix of cartilage. 
The extracellular matrix consists of ground substance (hyaluronan, chondroitin 
sulfates and keratan sulfate) and tropocollagen, which polymerises extracellularly into 
fine collagen fibres; collagen type II is the dominant form in collagen fibres of almost 
all types of cartilage [8]. The crosslinked collagen fibers networks confer tensile and 
shear resistance to the whole structure. At same time, the compressive resistance is 
derived from the electrostatic repulsion between the negatively charged aggrecan 
molecules [56, 57]. As the amount of matrix increases the chondroblasts become 
separated from each other and all cells are located isolated in small cavities within the 
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matrix. At the same time the chondroblasts differentiate into mature cartilage cells: 
chondrocytes [23, 58, 59].   
  Articular cartilage covers the surface of the diarthrodial joints in the human body. 
There is no surrounding perichondrium and is partly vascularised. Articular cartilage 
depends on the arrangement of chondrocytes and collagenous fibres and other ECM 
compositions, which is divided into three zones (Fig. 2-1): superficial tangential zone, 
middle zone and deep zone. Biochemically, besides the chondrocytes, there are full of 
type II collagen, and the aggregating proteoglycan aggrecan [60, 61]. Every zone of 
the articular cartilage is defined by different ECM element, or different concentration 
of compositions. However, in the whole articular cartilage, the collagen fibrils form a 
dense, highly interconnected matrix. Also, in this matrix, the negatively charged 
aggrecan bounds in large numbers to hyaluronic acid chains to form proteoglycan 
aggregates. These aggregates raise the osmolarity of the tissue, which triggers an 
influx of water, which increases the internal pressure of the tissue, giving cartilage its 
mechanical properties. From the most superficial zone to deep zone, aggrecan 
concentration greatly increases with tissue depth [62]. 
The underling bone tissue is a vascular tissue has self-regeneration ability. The 
bone tissue under cartilage can be divided into two parts: subchondral bone and 
underlying cancellous (or trabeular) bone. The subchondral bone is a dense layer of 
stiff bone containing rich type collagen I fibers and calcium phosphate ECM. The 
thickness of this layer is around 1 mm located between cartilage and the underling 
cancellous bones[63]. The cancellous bone has a porous structure and is surrounded 
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by bone marrow. The ECM of cancellous bone is constituted by 65% of calcium 
phosphate mineralized composition and 35 % of organic composition, such as Type 
collagen I secreted by osteoblasts [54].  
The osteochondral interface describes the interaction of calcified cartilage. 
Cartilage and underling bone are tightly contacted by this interfacial layer [64]. This 
zone forms an important interface between cartilage and bone for force transition, 
which attaches cartilage to bone and limited diffusion from bone to the deeper layers 
of cartilage. The thickness of the interface is a relatively constant percent of articular 
cartilage [65]. Structurally, collagen fibers extend from the deep region of articular 
cartilage to calcified cartilage through a wavy tidemark, which dissipates forces 
through the vertical orientation of collagen fibrils [10].  Calcified cartilage is 
interdigitated with subchondral bone, however, collagen fibers do not extend the 
bonder of calcified cartilage into the bone [10]. Cartilage and bone have different 
mechanical properties, thus, this interfacial layer is probably important for the load 
transfer between the two different tissues. The cells in this calcified zone are 
hypertrophic chondrocytes. And there are full of collagen in the ECM, especially 
collagen X. Collagen X is a short, non-fibril-forming collagen restricted to the 





Fig.2-1  Layered structure of osteochondral tissue and corresponding collagen fibers 
arrangement [68]. 
 
  Each zone of osteochondral tissue contains significantly different mechanical 
properties. Depending on different ECM constituents and architecture, the 
compressive modulus varies on orders of magnitude between each zone [1]. The 
approximate moduli of the superficial zone, deep zone, calcified cartilage, and 
subchondral bone are 0.079, 2.1, and 320 MPa, and 5.7 GPa [69].  
  Due to complexity of the biology and mechanics of this multilayered tissue, the 
challenges for osteochondral tissue engineering also focus developing a gradual 
changed biology and mechanical properties engineered constructs, which mimic the 
native tissues and ensuring proper integration with surrounding tissues and 




2.3. Osteochondral Defects 
  Osteochondral defect can be caused by bone bruises, osteochondritis dissecans, 
chondromalacia and osteoarthritis. Trauma caused by sports injury in articulating joint 
to excessive loading usually triggers the osteochondral construct bruising or the 
loosening of a fragment of osteochondral tissue known as osteochondritis dissecans 
[55, 70]. There are two main defects suffered by cartilage, which are defined as partial 
thickness and full thickness defects (Fig. 2-2) [34]. In short, the partial-thickness 
defects only affect the cartilage layer, while, the full thickness defects affect all layers 
form cartilage to bone region [34]. Unfortunately, cartilage is an avascular tissue with 
highly differentiated chondrocytes with low proliferation potential and metabolism 
level, which has intrinsically poor self-regeneration ability [71]. Once trauma appears 
on the cartilage surface, further degradation may happen [6, 71]. During the beginning 
stages, fissures form on the surface of articular cartilage. These defects will become 
larger and deeper with the destruction of cartilage while exposing the underlying 
subchondral bone by time [71]. When left untreated, inadequate natural healing will 
occur with low cell density and low normal articular cartilage ECM compositions [72]. 
When the defects reach the subchondral bone, the defects regeneration was faster and 
easier. With the vascular supply, progenitor cells with growth factors are allowed to 
migrate to the defects regions and regenerate the defects [71, 73]. However, the 
quality of the regenerated tissue is a mixture of fibro and hyaline cartilage, or even 
totally fibro-cartilage which is stiffer than native hyaline cartilage [34]. Moreover, 
these regenerated tissues cannot suffer normal joint movement compression; they 
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often degrade within 6-12 months [74]. Diseases, such as arthritis, also can damage 
the cartilage, resulting in inflammation, pain and reducing the mobility for patients 
[75, 76].  
 
Fig.2-2 The International Cartilage Repair Society cartilage injury classification [77]. 
 
2.4. Conventional Treatment 
  Non-surgical treatments are needed which include physiotherapy, glucosamine 
supplementation for slight cartilage defects; these methods can improve native 
chondrocytes to produce new ECM [78]. When there are cartilage tears formed by 
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injury, noninvasive arthroscopic techniques can be used for surgeon to remove the tear 
and smooth the cartilage surface. However, these methods cannot result in direct 
tissue repair.  
For serious partial or full-thickness defects, self-regeneration of the tissue is 
difficult, thus, surgical intervention methods are required [71, 79]. Autograft is one of 
the most common used methods. Healthy osteochondral grafts are harvested from 
patents’ own low load bearing areas and transferred in the knee to the defect part. This 
strategy is to penetrate into the subchondral bone region, which allows  blood to 
form in the bone region, taking the pre-differentiated cells, nutrient and growth factors 
from the bone marrow [63]. Although it is an effective treatment method currently, it 
may cause the donor site morbidity and pain. Furthermore, the limited availability of 
donor cartilage inhibits this method to treat large defects (larger than 6 cm
2
). In 
addition, even the defects are filled with healthy plugs, the integration region between 
transplanted plugs and surrounding tissue is still filled with fibrous cartilage [80].  
Allograft is similar method but have the potential to treat larger size defects than 
Autografts. It involves the transplantation of healthy plugs harvested from cadaver to 
fill the patients’ defects. This strategy has similar problems as Autograft. Besides 
these drawbacks, disease transmission and immuno-responses are also important 
concerns [78]. Microfracture is another most commonly used method. When defects 
reach or near the subchondrol region, holes are dug in the defect site to allow the bone 
marrow to flow out with cells to regenerate the defects. Unfortunately, these 
regenerated cartilages are usual fibrocartilage [81, 82]. Autologous chondrocyte 
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implantation, a procedure that consists of injecting patients’ chondrocytes in the 
defect part and then covering the defect with periosteal flap are starting to be used. 
But this method do not have inter-patient consistency, moreover, the surgical 
procedure is complex and hard to handle [20, 21].  
In most recently, a novel approach: juvenile cartilage/chondrocytes 
implantation attracted people’s attention. Compared with adults’ chondrocytes, 
chondrocytes form juvenile donor (<13 years old) have higher expansion rate, better 
ECM production ability and are immune privileged [83, 84]. However, some disease 
transmission possibilities still remain in traditional allotransplantation [22]. When all 
above methods are exhausted, prosthetics are employed. In this method, total joint is 
replaced with artificial materials, such as metal and plastic, is suitable for severe 
patients. This method has been done in more than 300,000 total knee replacements in 
the USA each year. But it also have many drawbacks, like dislocation, infection, 
damage to blood vessels, loss of range of motion, pain, etc [23].  
 
2.5. Tissue Engineered Osteochondral Grafts 
  The drawbacks in the above conventional treatments for osteochondral defects 
call for better solutions. With the improvement of supporting technologies in materials, 
biology and medical, there is a potential of using tissue engineering strategies to solve 
these problems. Tissue engineering has been defined as “an interdisciplinary field that 
applies the principles of engineering and the life sciences toward the development of 
 21 
 
biological substitutes that restore, maintain or improve tissue function” [85]. Tissue 
engineering uses natural or artificial materials, suitable cell sources and necessary 
chemical and physical stimulations to improve the regeneration of biofunctional tissue 
or organ in vitro or vivo. The choosing materials would be made into properly 
structured scaffolds, which act as templates for tissue growth, which mimics the 
natural ECM environment for cell growth and provides the necessary mechanical 
support for cells. For the aim to regenerate new tissue, the ideal scaffold should be 
degraded gradually and replaced by tissue own ECM. 
  Usually, there are two main goals in tissue engineering: (i) regenerate the 
small-scale injuries or defects, such as damage to cartilage defects, (ii) repair or 
replacement of more complex organs. In the first aim, the target tissues’ structure is 
not so complex. Cells from individual patients or donor can be injected with hydrogel 
materials or implanted with other degradable scaffold to the defect region. These 
implanted cells can stimulate and improve the defects or diseased tissue repair. 
However, for larger size or complex tissue regeneration, simple injection or 
implantation of cells does not work. Thus, growing tissues or organs in vitro by 
seeding synthetic scaffolds with patient or donor cells along with other necessary 
stimulation are required. For common cartilage or bone regeneration, only one type of 
cells may be needed. However, when the defects reach the subchondral bone, the 
whole multilayered osteochondral tissue regeneration by more complex cells, 
scaffolds or stimulation strategies will be required.  
  Various tissue engineering studies attempt to generate both the cartilage and 
 22 
 
bone to treat osteochondral defects. Cao et al experimented with osteochondral 
construct generation in vitro by using polycaprolactone scaffolds seeded with BMSCs 
and chondrocytes co-culture in vitro [86]. Holland et al tried to implant a cell free 
two-layered hydrogel scaffolds that can control release IGF-1 and TGF-beta 1 in the 
rabbit model to regenerate the osteochondral defects [87]. Grayson et al designed a 
perfusion bioreactor to culture biphasic scaffold seeded with human BMSCs in vitro 
[88]. Although the above studies and many other groups performed different 
strategies for osteochondral tissue regeneration, there are several elements identified 
as the most significant, which are: cell source, scaffold, biochemical/mechanical 
stimulations (Fig. 2-3). This study will focus on aspects of scaffold and biochemical 
stimulation to induce BMSCs towards chondrogenic, osteogenic and chondrocyte 
hypertrophic differentiation, which will be discussed in the following sections. 
 
Fig. 2-3 Diagram representing elements contributing to tissue engineering 











 The use of appropriate cells is the key factor in tissue engineering approach to 
successfully regenerate the osteochondral tissue. The presence of cells is important for 
tissue regeneration process because their ability of proliferation, migration, cell-cell 
interaction, bimolecular production and formation of matrix can significantly improve 
neotissue regeneration [24, 89, 90]. When using cells in tissue engineering, a few 
questions should be first considered. First of all, the number of cells initially seeded 
can influence the rate of cell-mediated processes involved in tissue formation. In fact, 
minimum thresholds of the number of cells may be required in new tissues formation. 
    Secondly, the cells can be autogeneic, allogeneic or xenogeneic, which arise  
issues such as donor shortage, immunologic responses [91]. Last but not least, cells 
can be differentiated cells; they also can be stem/progenitor cells, or cells that have 
been genetically modified to induce pluripotent stem cells or make specific molecules 
[73, 92, 93].  
 In osteochondral defect regeneration, the candidate cells can be differentiated cells, 
such as osteoblast and chondrocytes, or progenitor cells, such as bone marrow stromal 
cells (BMSCs) or adipose stem cells. When choosing the cell types, chondrocytes are 
one of the main cell types which have been used so far. However, it raises a problem for 
practical clinical use: harvesting chondrocytes from patients creates an additional 
injury; these new defects will not recover and might cause serious repercussions, such 
as osteoarthritis, with passing time [94]. In addition, to successful regenerate the new 
cartilage by tissue engineering method; a large number of cells will be needed. 
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However, when expanding chondrocytes in vitro, the chondrocytes dedifferentiate 
easily during 2D culturing and they lose the capacity to secrete the key cartilaginous 
ECM such as Type II collagen and aggrecan [95]. Moreover, chondrocytes are highly 
differentiated and they have a low capacity for proliferation [96]. Besides, report 
showed that under the osteogenic stimulation, the chondrocytes have low osteogenic 
response and cannot be used to generate the bone region [96]. Thus, additional 
osteoblasts are needed form patients’ bone tissue. The good self-production and 
differentiation capacity make stem cells become potentially better choices for 
osteochondral tissue engineering cell candidate. Embryonic Stem Cell (ESC) is one of 
these candidates. This type of cells has proven its potentials in forming various tissues 
and its use for cartilage regeneration was also being investigated [97-99]. However, 
its research and clinical use is discouraged on ethical grounds [100]. 
  To solve the above-mentioned issues, bone marrow stromal cells (BMSCs), 
another candidate for osteochondral regeneration [101], can be harvested from 
patients’ bone marrow, which can renew quickly. BMSCs can increase its cell 
numbers more easily in vitro [102], and BMSCs can be easily separated out from the 
bone marrow via their ability to adhere to tissue culture plastic. Hence they provide an 
immense reparative potential for clinical application. Depending on the cell 
stimulated environment, BMSCs are capable of differentiating into osteoblasts, 
chondrocytes, adipocytes and myoblasts in vitro and vivo [103-107], which avoid the 
need for invasive multisite biopsies that are required to isolate both chondrocytes and 
osteoblasts for bone and cartilage regeneration together in osteochondral problems. 
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Several other advantages during application make BMSCs one of the most attractive 
osteochondral tissue engineering candidates. Many research reports further support 
the idea that BMSCs is one of the most appropriate cell sources for osteochondral 
regeneration. Im et al used BMSCs instead of chondrocytes to modify ACI procedure 
and the formation of neocartilage in the animal models was observed after 14 weeks 
[108]. When compared with chondrocytes, BMSCs can heal the defects with better 
hyaline cartilage and better integration with host tissues [109]. Moreover, because of 
the low response of chondrocytes, during an osteochondral injury, the release of 
potent cytokines primarily targeted the MSC but not chondrocytes [96, 110, 111]. 
Besides the chondrogenic ability, BMSCs can also differentiate into osteoblasts and 
hypertrophic chondrocytes [105, 107]. A recent study showed that after BMSCs 
pre-differentiate to osteogenic and chondrogenic lineage, they could further regulate 
and induce the hypertrophic chondrocyte differentiation of undifferentiated BMSCs 
by co-culture [29], therefore, it support the idea that using BMSCs as a single cell 
source for multilayered osteochondral regeneration is possible.  
 
2.5.2. Scaffolds 
  The scaffold is considered as an important component of a tissue engineered 
osteochondral tissue, which provides a three-dimensional (3D) structure for new 
tissue growth. For special multilayered tissue regeneration requirement, osteochondral 
scaffolds must have porous structure, which allow vasculature invasion for bone 
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regeneration. The porous scaffold structure is also necessary for cartilage region 
formation as cartilage is an avascular tissue; porous scaffold can facilitate 
nutrient/waste transport via diffusion. However, porous scaffolds often allow only 
limited cell attachment and result in non-homogeneous cell distribution within the 
scaffold [39]. Moreover, cells (diameter: 5-30 µm) are of similar dimensions or much 
smaller than scaffolds, therefore seeded cells essentially encounter a 2D environment 
within the scaffolds, which fail to biomimic the 3D environment presented by 
collagen nanofibrils in the natural extracellular matrix. Collagen type I and II fibrils 
have diameters ranging between 50-500 nm, and nanofibrous substrates with similar 
dimensions are known to facilitate cell attachment, proliferation and ECM deposition. 
Studies also found that chondrocytes dedifferentiate and become fibroblastic when 
they are maintained on a 2D surface, but they can keep chondrocytic phenotype in 3D 
environments [86]. According to the tissues to be engineered, scaffolds can be 
fabricated by different techniques. Take spongy and porous scaffolds for bone and 
cartilage tissue engineering for example, they can be obtained by freeze drying, 
particulate leaching or 3D printing techniques [37, 63, 105, 112-115]. To further arrest 
cell loss from porous scaffolds, hydrogel can be used in combination with porous 
scaffolds to encapsulate cells and provide better 3D environments [116]. An ideal 
scaffold typically possesses the following characteristics: 
1). Biocompatible biodegradable.  
2). Porous. It should have sufficient interconnected pores that facilitate cell growth 
and nutrient/waste exchange.   
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3). Architecture or geometry. It is better for cell attachment, growth, proliferation and 
necessary mechanical support for tissue regeneration.  
 
2.5.2.1. Osteochondral Tissue Engineering Scaffold Materials 
 Current studies into the tissue engineering approach of osteochondral generation 
have focused on using natural scaffolds or synthetic biodegradable scaffolds with 
different cell types [34]. A variety of scaffolds used for osteochondral tissue 
engineering have incorporated a synthetic material, such as polymers and ceramics, 
into either the osteo or chondral region [34]. In polymer materials, the poly(L-lactide) 
and polyglycolide are the most commonly used as they have good mechanical 
properties and slow degradation rate [117]. When blending the polymers together, the 
degradation rate can be controlled. Schaefer et al. have created a blend of poly 
(lactic-co-glycolic acid) (PLGA)/ polyethylene glycol as co-polymer for 
osteochondral generation scaffolds; results showed that this kind of scaffold could 
induce high glycosaminoglycan deposition [118, 119]. Sherwood et al. fabricated a 
polymer/ceramic co-composite scaffold for osteochondral regeneration [120]. Another 
study showed that a two layered scaffolds induce both bone and cartilage regeneration, 
which was built by a L-PLGA/tricalcium phosphate layer for bone phase and a 
PLGA/L-polylactic acid for chondral phase [121]. Due to their synthetic nature, 
polymer and ceramic are both reproducible and mass-producible. Moreover, polymer 
scaffolds can be made by variety of methods into different structure, which makes 
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them popular in this field.  
   On the other hand, natural materials also arises the interests in osteochondral 
tissue engineering. Natural polymers such as collagen, chitin, silk fibroin, and 
bioresorbable polymers like the poly (α-hydroxy acids) have been most commonly 
used [13, 35, 122-124]. Many natural scaffolds can degrade in vivo without harmful 
by-products that often form in polymer degradation process [125]. Moreover, natural 
materials can provide better natural like environment, such as collagen, 
glycosaminoglycan, chitosan and silk. Type collagen I, a biological polymer that 
forms the main component of the ECM, is one of the most commonly used natural 
material. Collagen I have been made to microsphere scaffolds for multilayered 
osteochondral tissue generation in vitro [126]. Likewise, Brendan et al. successfully 
designed a Type collagen I and II two layered scaffolds bone and cartilage phase 
formation in vitro [124].  
 
2.5.2.2. Silk Fibroin and RADA peptides as Osteochondral Tissue Engineering 
Scaffold Material 
  Silk, a natural fibrous protein derived from Bombyx mori silk worms, possesses 
remarkable mechanical properties and a slow degradation rate, which will be 
susceptible to proteolytic degradation in vivo and be absorbed, though a longer period 
of time is required. These properties are suitable to support the healing tissue 
generation over a period of 6 to 12 months [35, 36]. Its properties of biocompatibility, 
morphologic flexibility, environmental stability and the ability for functionalization 
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via amino acid side chain modification to immobilize functional groups, make it 
useful as a scaffolding biomaterial [36-38]. It is found that silk will not likely induce 
hypersensitivity if the wax-like sericin coating is removed [37, 122, 127] . Sericin can 
be removed from raw silk by degumming process easily. Furthermore, Silk fibroin has 
been proven to have equivalence to collagen in supporting cell attachment and induce 
cell morphology and growth since it is a natural protein as well [128]. To further 
mimic the ECM structure, SF has been successfully freeze dried to sponge like 
structures which have been used in chondrogenic, osteogenic [129, 130] and 
osteochondral tissue generation [131, 132]. However, as mentioned above, porous 
scaffolds often allow only limited cell attachment and result in non-homogeneous cell 
distribution within the scaffold [39]. Moreover, cells seeded in porous scaffold attach 
on 2D environment, which fail to biomimic the 3D environment, which may induce 
chondrocytes dedifferentiate and become fibroblastic when they are maintained on a 
2D surface.  
  To solve this issue, the RADA self-assembly peptides can be used to 
encapsulate cells. The self-assembling peptides have similar mechanical behavior to 
those of natural collagen scaffolds [41]. RADA (AcN-(RADA)4-CONH2) is one of 
such materials, which self-assembles to form a three-dimensional hydrogel structure 
mimicking the extracellular matrix. These self-assembled nanofibrous scaffolds have 
more than 99% water content and possess excellent biocompatibility [133]. 
Self-assembling peptides form stable β-sheet structures in water. It is stable across a 
broad range of temperature and wide pH ranges. And one of the most important 
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characteristics is that nanofibres can give cells a proper growth environment which is 
similar to extracellular matrix [133, 134]. The generated nanofibres biomimic the 
natural ECM and enhance the attachment, growth and differentiation of a variety of 
cells [135, 136]. It has been successfully used to culture hepatocytes, chondrocytes, 
endothelial cells, BMSCs, neuronal tissue, fibroblasts and etc [135, 137-140]. It also 
has been proved as non-toxic in vivo; moreover, it can promote the regeneration of 
bone tissue in calvarias bone defects [141]. However, one drawback of RADA 
scaffold is it cannot endure high mechanical stress [142]. Thus by combined use 
self-assembly peptides and other materials with higher mechanical property makes 
self-peptide materials can be used in other hard tissues [45].  
 
2.5.3. Biochemical cues  
 Biochemical stimulation is caused by growth factors or other stimulation factors. 
Growth factors are small proteins or steroid hormone synthesized by several types of 
cells of the immune or musculoskeletal system. Growth factors bind to specific cell 
surface receptors and trigger complex intracellular signal transduction pathways that 
stimulate cellular growth, proliferation and cellular differentiation, which are important 
for regulating a variety of cellular processes. Several studies have tried to define the 
role of growth factors in cartilage and bone regeneration and the method to use these 
factors to regenerate cartilage, bone or osteochondral multilayered tissues [52, 87, 
143-146]. Expression of transforming growth factor-β (TGF-β) has been localized to 
 31 
 
sites of bone repair as well as sites of embryonic bone and cartilage formation in vivo 
[147, 148]. Reports also showed that the important roles of intracellular signaling 
cascaded influence by TGF-β in promoting chondrogenic gene expression [13, 149]. 
β-glycerophosphate is commonly used in osteogenic differentiation, which can induce 
BMSCs’ osteogenic differentiation and promoted ECM mineralization [143, 150-152]. 
Studies also showed that the presence of β-glycerophosphate may cause hypertrophy 
chondrocytes produce more Type Collagen X and form the mineralized ECM [153]. 
 
2.5.4. Cell-to-cell interaction and co-culture approach 
 Over the last four decades, co-culture has been used extensively in biological 
research to investigate cellular interactions and cell function. Two or more types of 
cells put together and cultured in the same environment. Cellular communication 
between cells in body includes several pathways [154]:  
 Endocrine signalling (via the blood stream) 
 Synaptic signalling (via nerve innervations) 
 Paracrine or autocrine signalling (signals released by one cell bind to membrane 
receptors of other cells 
 Juxtacrine signalling (signals exposed on the membrane of one cell are bound by 
a membrane receptor of another cell)  
 Gap junction communication (intracellular signal exchange). 
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Currently, co-culture methods has been already used in several tissues 
regeneration, such as vascular tissue engineering [155], bone and cartilage tissue 
engineering [156] et al. Moreover, to generate the multilayered tissue with interface 
structure, the co-culture strategy might necessary [157]. In the study of osteochondral 
tissue engineering, the multilayered tissue will be generated at same time: cartilage 
region, interface and subchondral bone region together. Thus, co-culture method is 
considerable. Osteochondral constructs are engineered by coculturing two cell types, 
usually chondrocytes and osteoblasts, in close proximity. Co-culturing chondrocytes 
and osteoblasts has proven to have the potential to regulate the formation of 
hypertrophic chondrocytes and holds promise in osteochondral interface regeneration 
[67, 154, 158, 159]. Tissue engineering employing co-culture and stem cell therapies 
could provide a possible direction for multilayered complex osteochondral tissue 
regeneration [144, 146, 160]. Bone marrow stromal cells (BMSCs), another candidate 
for osteochondral regeneration cell type, can differentiate into a variety of cell types, 
including: osteoblasts, chondrocytes and adipocytes as mentioned before [161]. This 
type of cells has also been proven that they can differentiate to 
osteogenic/chondrogenic lineage and further regulate and induce the hypertrophic 
chondrocyte differentiation of undifferentiated BMSCs [29]. Therefore, BMSCs can 
be used as a single cell source for whole osteochondral construct generation. Because 
different tissues in osteochondral engineered grafts need to regenerate, no matter 
which strategies and cell types are chosen, co-culture is a necessary step for 




2.6. Summary  
 In the investigation of osteochondral tissue engineering, it is important to 
understand the anatomical and physiological functions. Due to the poor self-healing 
ability of cartilage, when there are defects formation on cartilage, subsequent healing 
of the tissue is often suboptimal as inherently repaired cartilage will never be as 
strong as the original tissue. Moreover, the defects have huge chance to become more 
serious and affect the subchondral bone region over time. Thus, the surgical 
reconstruction becomes necessary when the defects cannot be healed. However, 
current surgical treatment methods, such as microfracture, allograft and autograft 
often bear many limitations including donor site morbidity, graft rejection, infection 
and unwanted fibro-tissue generation. This motivated the use of tissue engineering 
methods, which include proper cell sources, biodegradable grafts and necessary 
stimulation to induce targeted tissues regeneration. Due to the unique osteochondral 
multilayered structure, the process of regeneration should consider different tissue 
regenerating at same time. Among the elements affecting the success of multilayered 
osteochondral tissue engineering, the cell source and co-culture strategies are focused 
in this study. Bone marrow stromal cells derived from rabbit bone marrow are chosen 
for the cell source used in this investigation, which will be seeded onto silk fibrin 
scaffolds with RADA self-assembly peptides. This hybrid scaffold can provide both 
chondrogenic and osteogenic tissue growth. This cell seeded construct will then be 
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stimulated in different co-culture environments to induce osteochondral interface 





Stage1. Silk/RADA scaffold fabrication and 2D-3D co-culture model 
for osteochondral interface generation 
 
3.1. Introduction 
    Physiological osteochondral interface regeneration is a significant challenge. The 
present study aimed to design an appropriate scaffold and investigate the effect of the 
co-culture of chondrogenic rabbit bone marrow stromal cells with rabbit osteoblasts in 
a specially designed 2D-3D co-interface culture to develop the intermediate 
osteochondral region in vitro. The 2D-3D co-culture system was set up by first 
independently culturing chondrogenic rBMSCs on a scaffold and osteoblasts in cell 
culture plates, and subsequently placed in contact and co-cultured. 
 
3.2. Materials and Methods 
3.2.1. Scaffold preparation 
    Bombyx mori silk fibers were used in this study. Raw silk fibers were immersed 
in a degumming solution of 0.25% (w/v) Na2CO3 and 0.25% (w/v) sodium dodecyl 
sulfate (SDS) between 98°C and 100°C. After 30 minutes, the solution was refreshed. 
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This process was repeated until the sericin was removed. The degummed silk was 
rinsed with distilled water for 1 hour to remove the residual degumming solution 
before leaving it to air dry. The degummed silk then was dissolved in a mixture of 
Calcium Chloride, Ethanol and water (CaCl2–CH3CH2OH–H2O) (molar ratio = 1:2:8) 
at 65°C with continuous stirring. The resulting silk solution was dialyzed against 
distilled water using a SnakeSkin Pleated Dialysis Tubing (PIERCE, MWCO 3500). 
The concentration (w/v) of the dialyzed solution was determined and adjusted to 3% 
w/v using distilled water. 6 ml silk solution was transferred into petri dishes and 
frozen at -20°C followed by freeze drying for 24 hours. Freeze dried silk sponge 
scaffolds were fixed in 90% methanol for 10 minutes, and then rinsed with distilled 
water. The structure and porosity of the scaffolds were observed by scanning electron 
microscope (SEM) and micro-CT. All silk fibrin scaffolds were sterilized in 70% 
ethanol for 24 hours, and then rinsed with sterile PBS 3 times before use. To fabricate 
silk/RADA scaffold, silk fibrin scaffold were soaked in 60 µl of 0.5% (w/v) RADA  
(Sigma) peptide solution for 10 min, gently transferred into fresh PBS and rinsed with 
distilled water after 30 min to get the hybrid silk/RADA scaffold. The surface 
morphology of the hybrid scaffold was evaluated by scanning electron microscopy 
(SEM, JEOL JSM-5600LV and JSM-6701, Japan), after formaldehyde fixation, 





Fig. 3-1 the steps for silk fibroin scaffold fabrication. (A) Raw silk, (B) Silk fibres after 
degummed, (C) Making silk fibroin solution, (D) Dialysis, (E) Freeze drying, (F) silk 
scaffold, (G) SEM analysis showed the porous structure of silk scaffold.   
 
3.2.2. silk/RADA scaffold bio-analysis 
3.2.2.1. Cell proliferation and metabolism analysis for silk/RADA scaffold 
     Cell proliferation was assessed by quantifying DNA content using PicoGreen 
assay (Quant-iT, Invitrogen, CA) (n = 3, at each time point) [162]. Briefly, silk/RADA 
scaffold and control scaffold (silk scaffold) seeded with cells after 7, 14 and 21 days 
of culture were washed with PBS, freeze-dried, treated with lysis buffer and 
homogenized. The supernatant obtained after centrifuging the homogenate was mixed 
with PicoGreen dye and fluorescence intensity was measured at 520 nm wavelength 




3.2.2.2. Total collagen and glycosaminoglycans assays for silk/RADA scaffold 
    On the 7th, 14th and 21st day of culture, the total soluble collagen synthesized 
and secreted into the culture medium was determined by SirCol Assay (Biocolor, 
Northern Ireland) using previously described methods [163]. The culture medium was 
replaced by fresh DMEM with 5% FBS, 2 days before the day of assay, to ensure that 
only freshly synthesized soluble collagen was assayed. Absorbance of PicroSirius Red 
stained collagen was read at 540 nm (TECAN Microplate Reader, Magellan 
Instrument. Control and Data Analysis Software) to obtain the concentration of 
collagen in the medium, which was then multiplied with the total volume of medium 
collected from the respective scaffolds (n = 4) to give an estimate of the total amount 
of collagen secreted per scaffold over 2 days. DMEM-HG with 5% FBS was used as a 
“reagent blank” during the assay. 
     The total soluble sulfated glycosaminoglycans (GAG) synthesized and secreted 
into the culture medium were determined by Blyscan Assay (Biocolor, 
Newtownabbey, Northern Ireland) following the assay manufacturer’s protocol. The 
culture medium was harvested on days 7, 14 and 21. The absorbance measured at 
656nm, with 550nm as the reference wavelength, was matched with a standard 
calibration curve to determine the GAG content in the media.(n = 5).  
 
3.2.3. Cell culture and in vitro 2D-3D interface co-culture model design 
     Rabbit bone marrow-derived stromal cells (rBMSCs) were obtained from New 
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Zealand White Rabbits using a previously described protocol approved by the NUS 
Institutional Animal Care and Use Committee, National University of Singapore [164, 
165]. In brief, the marrow was isolated from the femur under sterile conditions. After 
centrifugation and wash, the bone marrow were cultured in DMEM (Gibco, 
Invitrogen, CA) containing 10% FBS, penicillin and streptomycin. After 1 week, 
hematopoietic cells were removed. When primary BMSCs became confluent, trypsin 
(0.25%) was used to detach the cells and the first passage cells were used for 
expansion. All cell cultures were maintained at 37 °C in an incubator with 5% 
humidified CO2. The medium was changed every three days. Tibia bone was 
aseptically taken and washed three times by PBS with 50 µg/ml streptomycin and 100 
U/ml penicillin. All adhering soft tissue was stripped away and the bone was cut into 
small pieces (10 X 5 mm). Bone pieces were soaked in 0.25% trypsin for 30 minutes 
in incubator and then transferred into a new T- 25 flask with high DMEM medium 
with 10 %FBS for 1 week culture. The medium was changed twice a week. Bone 
pieces were moved out after one week and the cells migrated from bone piece was 
continually cultured.  
Passage 3 rBMSCs and passage 4 osteoblasts were used in all tests in this 
study. 0. 5 million rBMSCs were seeded with 50µl 0.5% (w/v) RADA peptide (Sigma) 
solution on each silk scaffold, then cultured for a week in  chondrogenic medium 
comprising : high glucose DMEM supplemented with 10
-7
M dexamethasone, 1% 
ITS+ premix (BD), 50 mg/ml ascorbic acid, 1mM sodium pyruvate and 4mM proline. 
Chondrogenic differentiation was induced in the presence of 10 ng/ml Transforming 
 40 
 
Growth Factor β3 (TGF-β3) (R&D Systems, Minneapolis, MN). At the same time, 
10,000 osteoblasts were seeded on 24 well plates and cultured in high glucose DMEM 
supplemented with 10% fetal bovine serum (FBS).  After one week of independent 
culture, the scaffolds with chondrogenic rBMSCs (3D part) were transferred to the 
wells containing the osteoblasts (2D part) and co-cultured for 3 weeks in 
chondrogenic medium, with the culture medium being changed three times a week. 
During this period, scaffolds with chondrogenic rBMSCs were kept in contact with 
the osteoblasts layers (Fig. 3-2). A group of scaffolds with chondrogenic rBMSCs (3D 
part) cultured in chondrogenic medium in a new well without co-culture with 
osteoblasts (2D part) served as controls.  
 
 
Fig. 3-2 Osteochondral 2D-3D co-culture systems. rBMSCs were seeded with RADA 
peptide solution on each silk scaffold, then cultured for a week in  chondrogenic 
medium. At the same time, osteoblasts were seeded on 24 well plates. After one week 
of independent culture, the scaffolds with chondrogenic rBMSCs (3D part) were 
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transferred to the wells containing the osteoblasts (2D part) and co-cultured for 3 weeks 
in chondrogenic medium. 
3.2.4. Cell proliferation  
    The proliferation of rBMSCs was measured at the end of Week 1, 2, 3 and 4 of 
culture using Alamar Blue dye reduction assay (Invitrogen). Briefly, rBMSCs seeded 
scaffolds (n=5) were incubated in DMEM medium supplemented with 5% FBS and 
10% (v/v) AlamarBlue dye for 2 h. Absorbance values of 200µL of the media were 
measured at 570 nm and 600 nm using a 96-well microplate reader (Sunrise remote, 
TECAN) and the percentage reduction in dye, which is proportional to the viability of 
cells in the sample, was estimated by following the vendor’s protocol. 
Cell proliferation was assessed by quantifying DNA content using PicoGreen 
assay (Quant-iT, Invitrogen) after 2 weeks and 4 weeks of culture. Briefly, samples 
(n=3) were washed with PBS, freeze-dried, treated with lysis buffer and then 
homogenized. The supernatant obtained after centrifuging the homogenate was mixed 
with PicoGreen (Molecular Probes, Invitrogen) dye and fluorescence intensity was 
measured at 520 nm using a fluorescence microplate reader after excitation at 485 nm. 
 
3.2.5. Total RNA extraction, cDNA synthesis and real-time PCR analysis 
     Gene expression was measured for two study groups. In the first gene 
expression test, the effect of co-culture was investigated. At the end of Week 2 and 
Week 4 of culture, cell-seeded scaffolds (n=3 for each group) were harvested for test. 
In second gene expression test, the location of osteochondral interface formation was 
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identified and analyzed using only co-cultured samples. Samples from the ends of 
Week 1 and Week 4 were harvested and divided into two halves, the Top Half (TH) 
and the Bottom Half (BH), the bottom half being the part in contact with the 
osteoblast layer. All samples for the gene expression study were rinsed in PBS. Total 
RNA was extracted using the RNeasy Mini Kit (Qiagen, USA) following the 
supplier’s protocol. The final eluted RNA was stored at -20°C and reverse transcribed 
to cDNA using iScript cDNA synthesis Kit (BioRad). Real-time RT-PCR was 
performed in a real-time RT-PCR machine (iQ5 Multicolor Real-time PCR Detection 
System) using the iQ Green RT-PCR Kit (Qiagen, USA). Assays were run in 
triplicates for each sample. The primer sequences of selected genes for real-time PCR 
are summarized in Table 3-1[102, 166-168]. GAPDH was used as the housekeeping 
gene and relative expression levels for each gene of interest were determined. For two 
layered test, the results of TH were further normalized by results of BH.  
 
 




3.2.6. Biochemical test  
3.2.6.1. Total soluble Collagen assays 
Collagen fibril deposition in the matrix is preceded by soluble collagen secretion 
from the cells which is measured by the collagen assay used in this study. The total 
soluble collagen synthesized and secreted into the culture medium was determined by 
Picrosirius Red based colorimetric assay (SirCol
®
 Assay, Biocolor Ltd, Northern 
Ireland), following the vendor’s protocol. After Week 2, 3 and 4  of culture, the 
collagen concentration in the culture media were determined by measuring the 
absorbance at 540nm and comparing with a standard curve (n=5). To final calculation 
the collagen amount for co-culture group, culture medium from samples that only 
seeded with osteoblasts was used as reagent blank to calculate the collagen produced 
form osteoblasts.  
 
3.2.6.2. Total soluble GAG assays 
   The total soluble sulfated Glycosaminoglycans (GAG) synthesized and secreted 
into the culture medium were determined by Blyscan Assay for soluble sulfated GAG 
(Biocolor, Newtownabbery, Northern Ireland). The assay manufacturer’s protocol was 
followed. The culture medium was harvested at the end of Week 2, 3 and 4. The 
absorbance was measured at 656 nm, with 550 nm as the reference wavelength. The 
GAG content in the media was obtained by comparing with the standard calibration 




3.2.6.3. Calcium content analysis 
To investigate the calcium content in the ECM, co-cultured samples were cut into 
Top Half (TH) and Bottom Half (BH) to analyze calcium content. The test was 
conducted by using Sigma Calcium Kit solution (Sigma, US) following the supplier’s 
protocol. Briefly, samples were harvested at the end of week 4 and washed in PBS 
twice. The samples were then soaked in 500ul of 5% trichloroacetic acid (TCA) at RT 
for 30 minutes, and then centrifuged at 12,000rpm for 5min at RT. The supernatant 
was collected. 10ul of the sample and standards were taken in 96-well plates and 
100ul of Sigma Calcium Kit solution was added; before proceeding to record 
spectrophotometric readings at 575nm.  
 
3.2.7. Morphological characterization  
     To visualize and observe the distribution of live cells, cell-seeded scaffolds at 
the end of Week 4 were stained with fluorescein diacetate (FDA, Molecular Probes, 
Invitrogen Corporation). The scaffolds were incubated in 6µg/ml FDA/PBS solution 
at  room temperature for 3 min, rinsed with fresh PBS twice and soaked in PBS and 
the green-stained live cells were visualized immediately using an inverted 
fluorescence microscope (IX71 Inverted Research Microscope, Olympus). 
     Cellular morphology in the cell-seeded silk scaffolds was also characterized 
using SEM. Samples were harvested after 4 weeks of culture, formaldehyde fixed, 
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freeze dried for 24 h, sputter-coated with gold and observed by SEM (Joel 
TSM-5000).  
 
3.2.8. Histology and immunohistochemistry  
Histological examination of cell seeded scaffolds after 4 weeks of culture was 
performed. Scaffolds were harvested and fixed with 3.7% formaldehyde, dehydrated, 
embedded in paraffin with 10µm sections cut from each sample’s bottom surface and 
stained with hematoxylin and eosin (H&E) for histological observation. To investigate 
the mineralization of ECM, Alizarin red staining and Von Kossa staining were used in 
this test. To investigate the GAG in ECM, Alcian blue staining was used.  
To investigate ECM proteins – Collagen II and Collagen X produced by rBMSCs, 
immunohistology staining was used on the cryomicrotome (LIECA CM3050S) with a 
labeled streptavidin-biotin immunoenzymatic antigen detection system (UltraVision 
Detection System Anti-Mouse, HRP/DAB; LabVision, USA). Briefly, the sections 
were digested enzymatically with pepsin (1 mg/mL) for 30 min at RT, and then 
incubated with a mouse anti-pig monoclonal antibody (Sigma,USA). After that the 
horseradish peroxidase (HRP) labeled secondary antibody was used. Finally, all 
sections were counterstained by hematoxylin and covered by coverslips using 
permanent mounting medium.  
3.2.9. Statistical analysis 
    All data was expressed as means ± standard deviation. Single factor analysis of 
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variance (ANOVA) was used to compare the study groups using SPSS 13.0 software. 
p < 0.05 was accepted as statistically significant.  
3.3. Result 
3.3.1. Scaffold Characterization  
    The scaffold used in this study was a cylinder of 5 mm diameter and 3 mm 
thickness. Scaffolds were found to have interconnected sponge structures with 
uniform pores of 150 ±20 μm diameter (from analysis of SEM, Fig. 3-3 B, C). By 
using µ-CT observation, it was found that the whole scaffold structure was 
interconnected. (Fig. 3-3 E).  
 
Fig. 3-3 Scaffold morphology (A) scaffold cylinder with diameter=5 mm and 
thickness=3 mm. (B, C) SEM images of silk scaffold (35X and 100X). (D) µ-CT 3D 
image part of scaffold. (E) Slice section image of µ-CT showed that the mineral test 





Fig. 3-4 A: SEM image of silk/RADA scaffold (50000x) showing a peptide 
nanofibrous2 mesh covering the surface and pores of the scaffold, with structural 
connections between peptide nanofibers and the silk sponge/fibres. B: RADA peptide 
nanofibres (80000x)  
 
3.3.2. Silk/RADA bio-analysis  
3.3.2.1. Cell proliferation  
    PicoGreen assays showed that cell numbers increased significantly (3.5 ± 0.24 
µg/ scaffold, 3.9 ± 0.87 µg/ scaffold and 5.8 ± 0.27 µg/ scaffold on day 7, 14 and 21) 
in silk/RADA scaffold during three weeks of culture; the increase was not significant 
in the control scaffold (2.8 ± 0.51 µg/ scaffold, 3.5 ± 0.96 µg/ scaffold and 4.7 ± 0.52 
µg/ scaffold at day 7, 14 and 21). At all time points, cell numbers were significantly 
higher in both scaffolds  
3.3.2.2. Total soluble collagen and GAG assays 
    Total soluble collagen produced by both groups of BMSC-seeded scaffolds 
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increased significantly during three weeks of culture. At all time points, 
BMSC-seeded silk/RADA produced significantly more collagen (7.1, 2.2 and 2.2 
folds higher at day 7, 14 and 21) than BMSC-seeded controls. 
Total soluble GAG produced by both groups of BMSC-seeded scaffolds also 
increased significantly during three weeks of culture. BMSC-seeded silk/RADA 
produced more GAG (3.7, 1.8 and 1.6 folds higher at day 7, 14 and 21) than 
BMSC-seeded controls, the difference being significant on days 7 and 21. 
 
 
Fig. 3-5 Total (A) collagen and (B) GAG assays showing significantly increasing 
amounts of collagen and GAGs produced by BMSC-seeded scaffolds during three 
weeks of culture (*p< 0.05); BMSC-seeded silk/RADA scaffold generally produced 
significantly more collagen and GAG compared to the BMSC-seeded controls (#p< 
0.05). 
3.3.2. BMSC proliferation on scaffolds and cell morphology  
    Both co-culture group and control groups showed similar cell adhesion. SEM, 
HE staining and FDA staining showed that the rBMSCs distributed well throughout 
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the scaffolds (Fig. 3-6 Fig. 3-11 A, B). Cells displayed a spherical chondrocytes-like 
morphology (Fig. 3-6 A, E, F). Alamar Blue reduction results showed that during the 
4 weeks of culture, both control and co-culture groups proliferated.  During the 
whole culture period, Alamarblue reduction showed that both co-culture group and 
control increased significantly by time. Except Week 2, there was no much difference 
between groups. Picogreen assay showed (Fig. 3-7 B) that by co-culture, the cell DNA 
content increased over the culture period, but there were no significant differences 
between the two groups as measured on Week 2 and Week 4.  
 
 
Fig. 3-6 Cell morphology on scaffold (A) H&E staining for BMSCs seeded scaffold for 
4 weeks. (B) FDA fluorescence staining showed that cell distributed well through the 
scaffold. (C-F) SEM images for cell morphology analysis. Most cells maintained 




3.3.3. Effects of co-culture on collagen and GAG production  
    According to the results of the assays, an increase in production of collagen and 
GAG between Week 2 and Week 4 was observed for both co-culture and control 
groups. However for the co-culture samples, the collagen secretion significantly 
increased, and the GAG production was lower as compared to the control sample at 
the Week 4 time point. This indicated that the co-culture for 3 weeks resulted in ECM 
with a higher collagen but lower GAG content by compared with control group. Sircol 
assays showed that both the control group and the co-culture group produced 
significantly more collagen from week 2 to week 4 (Fig. 3-7 D). The result also 
showed that, though both groups produced similar amounts of soluble collagen after 
one week of co-culture, significant increase in collagen secretion can be found at 
Week 4 by co-culture with osteoblasts for 3 weeks. Similarly, GAG production in both 
group increased significantly with time, the production of GAG was lower by 
co-culturing with osteoblasts. However, the GAG production increased faster in 





Fig. 3-7 (A) AlamarBlue reduction showed that both groups proliferated during the 4 
week culture period. (B) DNA content analysis by PicoGreen test. (C) GAG production 
decreased by co-culture at Week 2 and 4 (C-1) Alcian blue staining for control group at 
Week 4, (C-2) Alcian blue staining for co-culture group at week 4. Control group had 
significantly more GAG staining than the co-culture group. (D) Collagen production 
increased by co-culture at week 4. (*, p< 0.05) 
 
3.3.4. q-PCR analysis for gene expression  
The effect of co-culture on transcription of both chondrogenic and hypertrophic 
chondrogenic markers was examined in this study. In the first gene test, when the 
chondrogenic rBMSCs on the scaffold were co-cultured with the osteoblast layer on 
the bottom of culture well, the expression of Aggrecan and Type II Collagen was 
significantly decreased by week 4 compared to controls (p<0.05, Fig. 3-8).  In 
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contrast, Type I Collagen gene expression was significantly upregulated by co-culture. 
Sox-9 expression was slightly upregulated by co-culture; however, the difference was 
not significant. In this study, MMP-13 expression was found only in the co-culture 




Fig. 3-8 Gene expression Study One: co-culture group compared with control group in 
Week 2 and Week 4. All gene expression was normalized by comparison with 
housekeeping gene GAPDH. (*,p< 0.05)  




Fig. 3-9 Gene expression Study Two: Comparisons of gene expression between BH and 
TH at Week 2 and 4. All gene expressions normalized by comparison with 
housekeeping gene GAPDH. (*,p< 0.05) 
 
To investigate the extent of the effect of osteoblasts on chondrogenic rBMSCs, the 
co-culture samples were separated into two halves: Top Half (TH) (in contact with 
chondrogenic medium) and Bottom Half (BH), connected to the osteoblasts layer via 
direct contact. The same gene markers as the first test were used in this test. During 
the first week of chondrogenic stimulation, chondrogenic gene markers: Aggrecan, 
Type II Collagen and Sox-9 were all expressed and there were no obvious differences 
between TH and BH (Fig. 3-9). Similarly, Type I Collagen expression was similar 
between these two parts at the end of Week 1. Moreover, no Type X Collagen or 
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MMP-13 was expressed after one week of chondrogenic culture without co-culture. 
However, after longer period of osteoblast co-culture, the gene expression of the two 
halves became different. The expression of Aggrecan and Type II Collagen on BH 
was significantly lower than TH and the expression of Type I Collagen and MMP-13 
in the BH was higher than the TH. Furthermore, Type X Collagen was expressed only 
in BH.  
 
3.3.5. 2D-3D interface co-culture effect on GAG, mineralization and collagen 
deposition in ECM  
    As shown in Fig. 3-7 C, deposition of the matrix was visualized by Alcian blue 
staining. Horizontal cross-sections of control group and co-culture group were 
examined. The results showed that GAG staining was visibly down regulated in the 
co-culture group compared to the control. These results were consistent with the 
quantitative GAG results (Fig. 3-7 C). For mineralization deposition tests, Alizarin 
Red and Von Kossa staining were used. As seen in Fig 3-7, minimal calcium deposits 
could be stained on the bottom region which was directly in contact with the 
osteoblast layer from the co-culture group (Fig. 3-10 B, D). There were no 




Fig. 3-10 (A, B) Von kossa staining for calcium deposition in samples. (C, D) Alizarin 
Red staining for calcium deposition in samples. (A, C) Control group, (B, D) 
Co-culture group. Scale bar=200 µm.  
 
      To evaluate the specific chondrogenic or hypertrophic chondrogenic ECM 
protein zones within the scaffold, immunohistochemistry techniques were used to 
analyze Type II Collagen and Type X Collagen. In comparison with the Control group, 
the Co-culture group samples contained lower concentrations of Type II Collagen. 
However, Type X Collagen could only be positively stained in the co-culture group 
(Fig. 3-11). Specific, Type X Collagen distribution was restricted in the bottom 





Fig. 3-11 Immuno-staining for Type II Collagen  and Type X Collagen (A, C, E) 
Control group, (B, D, F, G) Co-culture group. (A, B) H&E staining. (C, D) Type II 
Collagen staining. (E, F, G) Type X Collagen staining, (G) Vertical section of the 
co-culture group scaffold. Scale bar= 500 µm.  
 
3.3.6. Calcium content  
    To quantitatively analyze the effect of co-culture on calcium deposition, BH and 
TH parts of the co-cultured samples were analyzed, with results shown in Fig. 3-12, 
BH part has significantly higher calcium content (p<0.05), which was consistent with 




Fig. 3-12 Calcium content analysis for top half and bottom half (contacted with 
osteoblasts) for co-culture group. (*,p< 0.05) 
 
3.4. Discussion  
3.4.1. Fabrication silk/RADA scaffold for osteochondral tissue engineering 
The choice of appropriate biomaterials and scaffold design is crucial for success in 
tissue engineering strategies. Scaffolds for engineering load-bearing tissues such as 
bone, cartilage, tendon or ligament should not only be adequately strong, but also be 
biocompatible to permit seeded cells to lay down new tissue. Silk, because of its 
excellent mechanical properties, biocompatibility and slow degradation profile, is a 
promising candidate as a scaffolding biomaterial for engineering musculoskeletal 
tissues [35-37, 122, 130, 169]. Surface modification and coating strategies have been 
applied to tailor silk scaffolds to influence cellular response and enhance formation of 
specific tissue types. Silk scaffolds have been coated with natural ECM proteins such 
as collagen and GAGs to create a biomimetic interface that improved cell adhesion, 
proliferation and new tissue formation [170]. 
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    Because of its excellent mechanical properties, biocompatibility and slow 
degradation profile, silk is a promising candidate as a scaffolding biomaterial for 
engineering musculoskeletal tissues [35-37, 122, 130, 169]. Surface modification and 
coating strategies have been applied to tailor silk scaffolds to influence cellular 
response and enhance formation of specific tissue types. Silk scaffolds have been 
coated with natural ECM proteins such as collagen and GAGs to create a biomimetic 
interface that improved cell adhesion, proliferation and new tissue formation [170]. 
However, the microstructural morphology of silk scaffold did not completely mimic 
the natural ECM microenvironment; to be truly biomimetic, a scaffold’s fibers must 
be nanoscalar (similar to collagen fibrils) and significantly smaller than the resident 
cells [41]. The natural ECM-like nanostructure of nanofiber scaffolds derived from 
self-assembling peptides such as RADA16 has been shown to improve cell 
attachment and proliferation and has encouraged the use of these scaffolds in 
engineering diverse tissues ranging from cartilage and bone to liver and nerve [140, 
171]. 
    As hypothesized, the RADA-coated hybrid silk scaffold developed in this study 
combined the advantages of the silk scaffold and peptide nanofibers and further 
enhanced BMSC attachment, metabolism, proliferation. Furthermore, the 
non-cytotoxic environment of self-assembling peptides allowed use of the peptide 
solution as a vehicle for cell delivery. Unlike gravitational cell seeding, where seeded 
cells can be lost from the scaffold surface, cells delivered in peptide solution likely 
remain in situ, since RADA peptide nanofibers are stable for 2-4 weeks [171, 172]. 
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The large surface area presented by their nanofibrous structure and RGD-like 
cell-adhesion motifs on RADA peptides promote cell attachment to the scaffold [41, 
42]; L-amino acids released on peptide degradation can also potentially promote cell 
proliferation (reference). The RADA-coated hybrid silk scaffold promoted 
chondrogenic and osteogenic differentiation of BMSCs [135, 173-177].  This 
repertoire of increased cell proliferation, metabolism and fibroblastic differentiation 
indicates the potential of the BMSC-seeded scaffold for osteochondrol tissue 
regeneration. 
3.4.2. 2D-3D co-culture model for osteochondral interface regeneration 
The objective of this step of work was to develop a physiological 2D-3D interface 
co-culture system for osteochondral interface regeneration by using rabbit 
chondrogenic rBMSCs and osteoblasts. The 2D-3D interface model described here 
allows the interaction between a zone of chondrogenic rBMSCs on a scaffold to be in 
direct contact with an osteoblast layer for cell to cell interaction. The matrix 
production and the expression of specific markers showed that the chondrogenic 
rBMSCs in the 3D scaffold that were in the proximity of the osteoblasts showed a 
tendency to form the osteochondral interface. During the co-culture period, only one 
surface of the 3D scaffold and a fraction of the chondrogenic rBMSCs are in contact 
with the osteoblast layer. Thus, this model also provided a possibility to investigate 
the difference between contact dependent and contact independent effects of 
interaction between chondrogenic rBMSCs and osteoblasts. 
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    By compared with human BMSCs, rabbit BMSCs have been shown that their 
chondrogenic differentiation potential decreased faster. Thus, in our study, early 
passage (Passage 3) rBMSCs were used in whole experiment [178]. From the results, 
it was found that the cell proliferation was maintained during the whole culture period, 
both in control group and co-culture group. GAG has been reported as one of the most 
important matrix components of cartilage [179]. In this study we found that although, 
lower GAG was produced by osteoblasts co-culture via both quantitative and 
qualitative means, however, GAG production in co-cultured group increased faster 
than control by time. Thus, the production of GAG might not be down regulated by 
osteoblasts. On the other hand, the collagen production increased through co-culture 
by Week 4. This might be because the beneficial effects of stimulation factors from 
the osteoblasts improved collagen synthesis. In this 2D-3D interface co-culture model, 
chondrogenic rBMSCs co-cultured with osteoblasts resulted in downregulation of the 
chondrogenic markers and the appearance of the hypertrophic chondrogenic markers. 
By comparing the control and co-culture groups, cartilage related Type II Collagen 
and Aggrecan genes were downregulated significantly. In contrast, the expression of 
Type I Collagen increased via co-culture. The osteochondral interface has collagen- 
rich ECM, which mainly includes Type I, II and X Collagens [62, 180]. Thus beside 
Collagen II, the production of Collagen I contributed to regenerate the complicated 
osteochondral interface ECM. Several growth factors such as insulin-like growth 
factor 1 (IGF1), TGFβ3 and bone morphogenetic protein-2 (BMP-2) can improve the 
expression of Sox-9 [181]. In our study, the moderate upregulation of Sox-9 might be 
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caused by the stimulation factors produced by osteoblasts. From Dasuki’s report, the 
continued expression of Sox9 is necessary for chondrocyte hypertrophy in the early 
stage of differentiation [182]. Type X Collagen  and MMP-13 are well-known 
molecular markers for chondrocyte hypertrophy [183, 184]. By co-culture, Type X 
Collagen was expressed at week 4 and MMP-2 was expressed earlier on as well.  
This showed that this co-culture model truly has the potential to introduce 
hypertrophic chondrogenic rBMSCs differentiation.  
    On the basis of the second set of gene expression studies conducted, we tried to 
determine the spatial effect of osteoblasts on the chondrogenic rBMSCs. From the 
gene expression results for the top and bottom halves of the co-cultured scaffold, only 
the lower half showed Collagen X and MMP-13 expression, coupled with increased 
Collagen I expression. The downregulation of chondrogenic markers Aggrecan and 
Collagen II was also more prominent in the bottom half, thus we can state that 
osteoblasts tend to affect chondrogenic rBMSCs that are in direct contact or in close 
proximity to them. Finally, results from the matrix protein staining, mineralization 
staining and calcium quantities results all confirmed the findings of the gene 
expression study. After co-cultured with osteoblasts, the Type II Collagen in matrix 
decreased significantly as compared to the control group. On the other hand, Type X 
Collagen could only be stained in co-culture samples. To investigate the distribution 
of Collagen X in ECM, co-culture samples were vertically cross cut and it was found 
that Collagen X was  located in the very bottom most layer of the scaffold. 
Mineralization was thought to be a marker for the formation of the osteochondral 
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interface [65, 185, 186]. In our study, some calcium depositions were indicated in the 
bottom part of the co-culture samples. It seemed that in the bottom surface of these 
co-culture samples, there was a thin layer of mineralized ECM formed.  
    The above results show that our 2D-3D interface co-cultures system might have 
the ability to induce the chondrogenic rBMSCs to become hypertrophic chondrocytes 
and that this kind of effect was not uniform throughout all the cells in the scaffold.  
Only the bottom surface that was in direct contact with the osteoblasts had the 
tendency to form the osteochondral interface. In this step of work, by using this 
directly contacted model, chondrogenic BMSCs has been shown the potential to 
generate the osteochondral interface. However, the mechanism was still unclear, the 
key factors of stimulation should be deeper investigate in future studies. To better 
understand the mechanism, different co-culture models, such as directly contacted 
model, indirectly model that only allows the medium exchanged between different 
types of cells [1], might be considered. The osteochondral interface was generated by 
this co-culture approach, however, the whole osteochondral multilayered tissue 
included subchondral bone also. Thus, in next step of work, the aim of study should 
try to generate the whole osteochondral constructs, which include cartilage region, 




3.5. Concluding remarks  
A novel scaffold possessing a hierarchy comprising - silk microsponge and peptide 
nanofiber mesh - was developed by coating self-assembled RADA peptide nanofibers 
on a silk-based microfiber- sponge scaffold. Compared to the control 
(microfiber-reinforced sponge scaffold), BMSC-seeded silk/RADA scaffolds showed 
enhanced cell proliferation, BMSC-seeded RADA-coated scaffolds also produced 
increasing amounts (amount produced being higher than in control scaffolds) of total 
collagen and GAGs during the culture. The second step of study demonstrated a 2D-3D 
interface co-culture system for osteochondral interface generation. Results revealed 
that specific spatially controlled regulation from osteoblasts in the 2D-3D co-culture 
system could help to introduce hypertrophic differentiation of chondrogenic rBMSCs 
on the scaffold and improve the calcified cartilage-like ECM formation in the scaffold. 
We have thus shown that this co-culture method has the potential to induce the 







Stage 2: Development of a 3D-3D co-culture model for osteochondral 
interface and multilayered constructs generation in vitro  
 
4.1. Introduction 
This stage of study was based on the cell-cell interactions between chondrogenic 
and osteogenic BMSCs. Some studies had shown that under the regulation effects of  
osteoblasts, chondrocytes would be able to differentiate into hypertrophic 
chondrocytes  [67]. On the other hand, BMSCs could differentiate into osteoblasts 
and chondrocytes after specific stimulations [187-190], supporting the possibility that 
BMSCs can be used as the only cell source to generate the whole osteochondral tissue 
and interface. Therefore, by co-culturing chondrogenic and osteogenic differentiated 
progenies, a whole osteochodondral construct with osteochondral interface could be 
regenerated, as reported in this chapter. In this study, two pieces of silk sponge 
scaffolds seeded with BMSCs and then glued with RADA self-assembly peptides 
aimed to engineer a whole osteochondral construct contained intermediated and 
osteogenic sections were investigated.  
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4.2. Materials and Methods 
4.2.1. Scaffold preparation  
     Scaffold fabrication method has been described in section 3.2.1 in Chapter 3.   
 
4.2.2. Cell culture and in vitro 3D co-culture model 
    The method of obtaining Bone marrow-derived stromal cells (BMSCs) from 
New Zealand White Rabbits has been presented in section 3.2.3 in Chapter 3. Passage 
3 rabbit BMSCs were used in all tests. 0. 5 million BMSCs were mixed with 50µl 0.5% 
RADA peptide (Sigma) solution then seeded on each silk scaffold, and was cultured 
for two weeks in chondrogenic medium: high glucose DMEM supplemented with 
10
-7
M dexamethasone, 1% ITS+ premix, 50 mg/ml ascorbic acid, 1mM sodium 
pyruvate and 4mM proline. Chondrogenic differentiation was induced in the presence 
of 10 ng/ml Transforming Growth Factor β3 (TGF-β3) (R&D Systems, Minneapolis, 
MN), and osteogenic medium: high glucose DMEM supplemented with 10% fetal 
bovine serum (FBS), 10
-7
M dexamethasone, 50 mg/ml ascorbic acid and 10nM 
β-glycerophosphate (Sigma).  After two weeks of culture scaffolds in different 
medium were combined by using RADA self-assembly peptide and co-cultured for 
another 2 weeks by using cocktail culture medium: high glucose DMEM 
supplemented with 2% FBS, 10
-7
M dexamethasone, 1% ITS+ premix, 50 mg/ml 
ascorbic acid, 1mM sodium pyruvate, 4mM proline and 10nM β-glycerophosphate 
(Sigma). Culture medium was changed three times a week. Two control groups were 
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designed in this study: 1) two osteogenic pieces combined control group (OS-control) 
and 2) two chondrogenic pieces combined group (CH-control).All samples were 
cultured in cocktail culture medium and all the following tests were done after 
co-culture. All tests were done after co-culture and time points were all recorded as 
after co-culture.  
 
 
Fig. 4-1 Osteochondral co-culture system: rBMSCs are mixed with RADA peptide 
solution then seeded on each silk scaffold, and are cultured for two weeks in 
chondrogenic medium and osteogenic medium for two weeks. Then these culture 
scaffolds in different medium were combined by using RADA self-assembly peptide 
and co-cultured for another 2 weeks by using cocktail culture medium. 
 
4.2.3. Total RNA extraction, cDNA synthesis and real-time PCR analysis 
Three gene expression tests were performed here. In the first gene expression test, 
the effect of co-culture was investigated. After one week and two weeks of co-culture, 
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samples from the co-culture group and the two control groups (n=3 samples for each 
group) were harvested. In the second gene expression test, the formation of 
osteochondral zones was analyzed in co-culture samples alone. Samples from the 
co-culture group—Week 2 were harvested and split into two parts: the Top Layer 
chondrogenic layer and the Bottom Layer osteogenic layer to evaluate and compare. 
In the final test, the location of hypertrophic chondrogenic cells was also investigated 
in the co-culture group only. The whole osteochondral construct was divided into four 
layers and tested. The method of RNA extraction, cDNA synthesizing was presented 
in section 3.2.5 in Chapter 3. The primer sequences of selected genes for real-time 
PCR were summarized in Table 4-1 [102, 166-168] . GAPDH was used as the 
housekeeping gene and relative expression levels for each gene of interest were 
determined. The amplification was performed in triplicates; data were analyzed for 
relative expression using the ΔΔCt method.  
 




4.2.4. Total GAG assays 
The total insoluble sulfated glycosaminoglycans (GAG) produced on scaffolds 
was tested on Week 2 in three groups. To further analysis the influence from 
co-culture, co-culture samples were separated as chondrogenic part (CH-PART) and 
osteogenic part (OS-PART) and compared with one piece from osteogenic control 
(OS-control) and chondrogenic (CH-control) control group. Samples (n = 3 
samples/group) were harvested and washed by PBS for 3 times. 500ul of 0.25mg/ml 
pepsin solution with 0.5% Triton X 100 and 0.25 M HCl was added in each sample in 
a 2 ml central tube; samples were shaking in 37 °C for 2 hours. The digested solutions 
were harvested and neutralized by NaOH, then determined by were determined by 
Blyscan Assay for soluble sulfated GAG (Biocolor, Newtownabbery, Northern 
Ireland). The procedure followed the vendor’s protocol. The absorbance was 
measured by 96-well microplate reader (Sunrise remote, TECAN) to calculate the 
percentage reduction in dye at 656 nm wavelength, with 550 nm as the reference 
wavelength. The GAG content was obtained by calibration with the standard 
calibration supplied in the assay kit. 
 
4.2.5. Morphological characterization  
Cellular morphology in the cell-seeded silk scaffolds was also characterized 
using scanning electron microscope (SEM). Samples from the co-culture group were 
harvested after 2 weeks, and then were formaldehyde fixed, freeze dried for 24 h, 
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sputter-coated with gold and observed by SEM.  
 
4.2.6. Histology  
Histological examination of cell seeded scaffolds after 2 weeks of co-culture 
was performed. Scaffolds were harvested and fixed with 3.7% formaldehyde, 
dehydrated, embedded in paraffin with 10 µm sections cut from each sample and 
stained with hematoxylin and eosin (H&E) for histological observation. To investigate 
the mineralization of ECM, Alizarin red staining were used in this test. To investigate 
the GAG in ECM, Alcian blue staining was used. To investigate ECM proteins – 
Collagen II and Collagen X produced by BMSCs, immunohistology staining was used 
on the cryomicrotome (LIECA CM3050S) with a labeled streptavidin-biotin 
immunoenzymatic antigen detection system (UltraVision Detection System 
Anti-Mouse, HRP/DAB; LabVision, USA). The method of staining was presented in 
section 3.2.8 in Chapter 3.  
 
4.2.7. Statistical analysis 
All data are expressed as means ± standard deviation. Single factor analysis of 
variance (ANOVA) was used to compare the study groups using SPSS 17.0 software. 




4.3. Results  
4.3.1. Osteochondral Co-culture Construct  
As shown in Fig. 4-1, the osteogenic-chondrogenic co-culture constructs 
developed in this study combined 3D culture of chondrogenic BMSCs with 3D 
culture of osteogenic BMSCs. H&E staining (Fig. 4-2 D-F) of a cross-section of the 
co-cultured sample showed that cells distributed well within the whole constructs and 
were embedded within rich ECM. In addition, the interface gap between the two parts 
was partly covered by tissue. 
 
Fig. 4-2 Macroscopic image of the construct and histology analysis of the two layered 
osteochondral constructs co-cultured after 2 weeks (B) Alcain blue staining, (C) 
Alizarin red staining.  (D-F) H&E staining, chondrogenic region (D), interface region 
(E), osteogenic region (F). Cells are indicated by arrows (B, C Scale bar = 500µm; D-F 




4.3.2. Total GAG deposition 
     For GAG production, both in week one and week two, co-culture group and 
chondrogenic control group have significantly higher GAG production than 
osteogenic control group. However, by 2 weeks of co-culture, the production of GAG 




Fig. 4-3 (A) GAG assays showing significantly higher amounts of GAGs produced by 
BMSCs in chondrogenic control group than co-culture group and osteogenic control 
group in week 2. (B) The GAG amount was decreased by co-culture in chondrogenic 




4.3.3. Effect of Osteogeneic-chondrogenic Co-Cultures on BMSCs differentiation  
     Quantitative real time-PCR was used in this study to investigate the regulation 
by the co-culture model. In the first gene expression study, samples from the 
co-culture group and two control groups were harvested in week 1 and week 2 after 
co-culture. Results (Fig. 3) showed that by co-culture Type II Collagen decreased 
obviously as compared to the chondrogenic control (CH-control). Similarly, the 
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expression of the Aggrecan decreased significantly in week 2. But, the expression of 
both of these two genes was still two fold higher than the osteogenic control 
(OS-control).   
 
Fig.4-4 Gene expression analysis study one:  normalized expression levels of 
chondrogenic, osteogenic and hypertrophy-related genes in three groups after 7 and 14 
days of co-culture (* p < 0.05).  
 
In contrast, by co-culture Type I Collagen was upregulated compared to CH-control 
and still slightly lower than OS-control. For Osteonectin and Runx-2 expression, the 
co-culture led to significant upregulation . Moreover, Type X Collagen was expressed 
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in both the co-culture group and CH-control group at both time points. In the first 
week, during co-culture, the expression of Collagen X was 2 fold higher than 
CH-control. However, in week two, CH-control seemed to have slightly higher Type 
X Collagen expression.  
 
4.3.4. Osteochondral multilayered constructs with interface generation   
    In the second set of gene expression tests, co-culture samples which were 
co-cultured for 2 weeks were harvested and separated into the chondrogenic part 
(CH-part) and the osteogenic part (OS-part) to analyze the gene expression. Fig. 4-5 A 
showed that in this co-culture model, both CH-part and OS-part successfully 
demonstrated chondrocytes and osteoblasts like gene expressions. The Collagen II 
expression in CH-part was obviously higher than OS-part, in addition, Aggrecan in 
CH-part was 5 fold higher than OS-part. On the other hand, the expression of Type I 
Collagen and Osteonectin in OS-part was 2 fold higher than CH-part. In the co culture 
samples, CH-parts seemed had similar level of RunX-2 expression.  Collagen X and 
MMP-13 are commonly used hypertrophic chondrocytes markers [183, 191], both of 
these markers in CH-part were expressed significantly higher than in the OS-part.  




Fig. 4-5 (A) Gene expression analysis two:  normalized expression levels of 
chondrogenic, osteogenic and hypertrophy-related genes in chondrogenic part and 
osteogenic part from co-culture group after 2 weeks of co-culture (* p < 0.05). (B) Gene 
expression analysis three: normalized expression levels of chondrogenic, osteogenic 
and hypertrophic-related genes in Chondrogenic top part,  Chondrogenic  middle part,  
Osteogenic  middle part and Osteogenic  top part from co-culture group after 2 weeks 
of co-culture (* p < 0.05). 
 
In addition, to locate the hypertrophic differentiation zones in the whole 
multilayered construct,  both CH-part and OS-part were subsequently separated into 
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another 2 layers: CH-TOP, CH-MID, OS-MID and OS-TOP and analysed for 
hypertrophic chondrocyte  gene markers Collagen X, MMP-13, also one 
chondrogenic marker Aggrecan and one osteogenic marker: Osteonectin. From results, 
the differences between layers were clearly observed. The hypertrophic gene markers 
were statistically higher in the two mid layers; especially the expression of Type X 
Collagen in CH-MID layer was 2 fold to 3 fold higher than the other layers. 
Furthermore, by interaction between the two pre-differentiated BMSC scaffolds, 
Aggrecan expression was evidently downregulated in CH-MID part and Osteonectin 
expression in OS-MID part was also downregulated.  
 
4.3.5. Histology and SEM  
    From Fig. 4-6, the osteochondral part, interface and chondrogenic part were 
clearly observed. The morphology of cells and ECM was visibly different between 
these two parts. Moreover, some tissue grew across the gap and tended to integrate the 
layers into a whole.  Alizarin Red staining results (Fig. 4-2 B) showed that the 
highest amount of calcium was deposited in the osteogenic part; and in the interface 
region, fewer calcium deposits also could be stained. However, in comparison with 
the osteogenic part, no calcium was stained in the chondrogenic layer. In contrast, the 
Alcian blue staining showed that in the chondrogenic part, there was obviously higher 
amount of GAG distributed in ECM compared to the estrogenic part. 
Immuno-staining analysis for Type I Collagen I, Collagen II and Type X Collagen of 
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the multilayer co-culture osteochondral constructs was performed. From the results 
(Fig. 4-7), Collagen I and II were stained in whole constructs, however, the osteogenic 
part has a higher amount of Collagen I, and in contrast, chondrogenic part has higher 
amount of Type II Collagen. Type X Collagen was slightly stained in the whole 
construct, and the chondrogenic layer seemed only to have a slightly higher amount. 
 
 
Fig. 4-6 SEM photomicrographs showing two layers fused together after 2 weeks of 
co-culture (A). The ECM in the Osteogenic part covered almost all scaffold pores and 
star shaped osteoblast-like cell morphology can be found in this region (indicated by 
arrows) (B). Chondrocyte-like cells could be found in Chondrogenic part (indicated by 
arrows) (C). Some gap between two layers was covered by chondrocyte like cells with 





Fig. 4-7 Immuo-histology analysis of the two layered osteochondral constructs 
co-cultured after 14 days (A) Type Collagen I (B) Type Collagen II, (C) Type Collagen 
X.  
 
4.4. Discussion  
     In this study, we investigated the potential of co-cultured chondrogenic and 
osteogenic BMSCs for multilayered osteochondral construct formation and functional 
interface generation. Rabbit derived bone marrow stromal cells (BMSCs) were 
cultured in a bio-inspired 3D silk fibroin scaffold for osteogenic and chondrogenic 
pre-differentiated culture, then combined using RADA peptide hydrogel to engineer a 
multilayered osteochondral constructs. The co-culture model facilitated BMSC 
proliferation, production and deposition of collagen and upregulation of gene 
expression of osteochondral interface-specific ECM proteins, suggesting the 
differentiation of pre-differentiated BMSC’s into hypertrophic chondrocytes 
phenotype. Moreover, multilayered osteochondral constructs were successful 
generated by this co-culture system. 
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4.4.1. Osteogenic/chondrogenic BMSCs co-culture system introduced the 
hypertrophic chondrogenic differentiation 
Hypertrophic chondrocytes are the main cell type in the osteochondral interface 
region [62, 180].Co-culture has been reported as a possible method to introduce 
hypertrophic chondrocyte differentiation by several recent studies [67, 192]. 
Osteoblasts have been thought  to have the ability to stimulate chondrocytes into 
hypertrophic differentiation[67]. In addition, Cheng et al reported that 
pre-differentiate osteogenic/chondrogenic   BMSCs could induce  BMSCs 
differentiation into  hypertrophic chondrocytes [29]. In this study, the result showed 
that our co-culture system could also successfully guide the formation of hypertrophic 
chondrocytes from pre-osteogenic and pre-chondrogenic BMSCs co-culture. The first 
gene expression study showed that, co-culture regulated several gene expressions, 
including chondrogenic, osteogenic and hypertrophic gene expression. Type II 
Collagen and Aggrecan were downregulated by co-culture compared to the 
chondrogenic control. It is possible that the hypertrophic differentiation might have 
downregulated some chondrogenic markers. The GAG content results provided 
similar results. Jiang et al also reported that during co-culture, GAG deposition was 
obviously decreased [67].  In contrast Type I Collagen and Osteonectin were 
upregulated by co-culture compared to chondrogenic control, falling short of the 
osteogenic control. Osteonectin is one of main molecules involved in tissue 
mineralization[180, 193], thus the upregulation expression of Osteonectin might be 
favourable for the formation of osteochondral calcified ECM. Moreover, the 
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significant upregulation of Runx-2 proved that co-culture influenced the chondrogenic 
BMSCs maturation and expressed  hypertrophic gene markers on the scaffold [194]. 
Similarly, Type X Collagen is considered as the main hypertrophic marker [29, 185, 
191, 192]. In our study, Type X Collagen appeared in week 1 in co-culture group, 
which was significantly higher than the chondrogenic control group, at same time; 
there was no expression in osteogenic control group in both time points. However, we 
also found that the expression of Osteonectin, Runx-2 and Type Collagen X was all 
increased obviously in the chondrogenic control. The likely cause might be from 
stimulation resulting from the β-glycerophosphate in the cocktail co-culture medium. 
The presence of β-glycerophosphate could induce hypertrophy[153].  
 
4.4.2. Generation of multilayered osteochondral construct with osteochondral 
interface.  
The final aim in osteochondral tissue engineering is to engineer  a whole 
osteochondral tissue with cartilage layer, intermediated calcified cartilage layer and 
subchondral bone layer [12, 195]. Chondrocytes and osteoblasts are two main cell 
sources for osteochondral tissue generation [180]. However, the harvesting  of 
chondrocytes may cause a secondary  injury to patients [196]. Cheng, et al reported a 
method  for the formation of an osteochondral multilayer, in vitro using only stem 
cells [29]. From the results of this study, we provide another possible method using 
only BMSCs as the cell source, to engineer an osteochondral multilayer constructs. 
Also the results showed that the pre-osteogenic and pre-chondrogenic BMSCs can 
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interact with each other to generate the osteochondral interface and the whole 
multilayered osteochondral construct. The quantitative RT-PCR results confirmed the 
formation of the multilayered structures. In the chondrogenic part, obviously higher 
Collagen II, Aggrecan expressed. In contrast, in the osteogenic part, Collagen Type I 
and Osteonectin was 2 fold higher than the chondrogenic part. SEM analysis and 
histology study both confirmed this result. In the chondrogenic layer, cells kept 
spherical chondrocyte like morphology embedded in a GAG and Collagen II enriched 
ECM. In contrast, in the osteogenic layer, star shaped osteoblast -like cells were 
embedded in a mineralized ECM with higher Collagen I. Moreover, some tissue grew 
across the gap between the two layers.  
The formation and location of osteochondral interface were another aim of this 
study. Significantly higher Type X Collagen and MMP-13 were found in the 
chondrogenic part in the co-cultured samples. As we mentioned before, the cocktail 
co-culture medium seemed to improve the chondrogenic BMSCs hypertrophy. To 
further investigate the stimulation of hypertrophy in the osteogenic part, the co-culture 
sample was separated into 4 layers. The results showed that the chondrogenic BMSC 
in direct contact with the osteochondral part had the highest expression of Collagen X 
and MMP-13, [183, 192]. In addition, the Alizarin red staining showed that slightly 
calcified ECM began to form in this layer. At the same time, the Aggrecan and 
Osteonectin expression results showed that the efficiency of osteogenic/chondrogenic 
interaction was based on the distance.  
In this study, a cocktail co-culture media was used during the co-culture period for 
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the test as well as control cases. The RT-PCR results report the upregulation of 
Collagen X in both the co-culture as well as the chondrogenic control samples. This 
may be due to the presence of β-glycerol phosphate in the osteogenic component of 
the cocktail medium, which is known to induce hypertrophy in differentiated 
chondrocytes. Therefore, in future work, efforts to isolate chondrogenic BMSCs from 
the osteogenic constituents of the media may enable us to better study the effect of 
osteogenic-chondrogenic cell interaction upon chondrocyte hypertrophy. Secondly, 
the RADA peptide gel can join the chondrogenic and osteogenic layers, and provide 
an ECM like environment for cell migration and growth in it [44, 136], however, a 
gap between these two layers still could be observed and did not fully enrich with 
cells and ECM. Thus, an optimal method that can improve better fusion can be used 
in future design.  
 
4. 5. Concluding remarks 
This study reported the pre-chondrogenic/pre-osteogenic BMSCs co-culture 
system had the potential to induce chondrogenic hypertrophy. Furthermore, this 
system provided a new method of fabricating a multilayered osteochondral construct 
using rabbit bone marrow stromal stem cells only and a silk fibroin/peptide scaffold. 
By using this method, a cartilage like zone that full of GAG and Collagen II, a 
subchondral bone like zone with mineralized ECM enriched with Collagen I and 






Stage 3. Design and fabricate an appropriate co-culture system and 
use it in osteochondral tissue engineering 
 
5.1. Introduction 
In this step of study, we presented a method using rabbit bone marrow stromal 
cells (BMSCs) cultured on a silk/RADA peptide scaffold in a specially designed 
two-chambered co-culture well for the generation of multilayered osteochondral 
constructs in-vitro. This specially designed two-chambered well can simultaneously 
provide osteogenic and chondrogenic stimulations to the cells located in different 
regions of the scaffold. This co-culture approach could provide specific chemical 
stimulation to BMSCs located on different layers within a single scaffold, resulting in 
the formation of multilayered osteochondral constructs containing, cartilage like and 
subchondral bone like tissue, as well as the intermediate osteochondral interface. The 
whole constructs were evaluated using gene expression, biochemical, structural and 
histological tests for multilayered organization. Specially, the formation of 
hypertrophic chondrocytes as a result of the co-culture, and the location of these 
hypertrophic chondrocytes within the whole construct were investigated.  
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5.2. Materials and Methods 
5.2.1. Scaffold preparation  
Scaffold fabrication method was presented in section 3.2.1 in Chapter 3. 14 ml 
the silk solution was transferred into a petri dish and frozen at -20°C and then 
freeze-dried for 24 hours. After totally drying, the silk sponge scaffolds were fixed in 
90% menthol for 10 minutes, and then washed several times with distilled water [197, 
198]. The silk sponge was punched into cylindrical silk sponge scaffolds 5 mm in 
diameter and 4.5 mm in height. All scaffolds were sterilized with 70% ethanol for 24 
hours, then rinsed with PBS 3 times and soaked in PBS before use. The RADA 
self-assembly (Ac-RADARADARADARADA-CONH2, Sigma) peptide was 
prepared as 0.5% w/v and added during the cell seeding process. After treated with 
mediums, RADA formed hydrogel inside the silk sponge scaffold and embed the 
cells.  
 
5.2.2. Two-chambered co-culture well fabrication and co-culture system design 
A static two-chambered 8-well co-culture plate was designed and fabricated 
(Fig. 5-1). Polycarbonate was chosen for fabrication as it is both autoclavable and 
reusable. Each well (10 mm diameter, 10 mm thickness) contained a polycarbonate 
septum fixed vertically in the middle of the well adhered with polydimethylsiloxane 
(Sylgard 184 Silicone Elastomer, Dow Corning). A hole of diameter 4.5 mm was 
provided in the septum for the horizontal placement of a BMSC seeded silk/peptide 
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scaffold. Osteogenic and chondrogenic stimulation media could be each placed in the 
2 compartments separated by the septum to introduce the BMSCs’ osteogenic, 
chondrogenic and hypertrophic differentiation on different layers of single scaffold 
simultaneously. 
 
5.2.3. Cell culture and co-culture in two chambered wells  
Bone marrow stromal cells (BMSCs) were obtained from New Zealand White 
Rabbits using a previously described protocol in section 3.2.3 in Chapter 3, which 
approved by the NUS Institutional Animal Care and Use Committee, National 
University of Singapore [164, 167, 198]. Passage 3 BMSCs were used in all tests in this 
study. 0. 5 million BMSCs were seeded with 50µl of 0.5% RADA peptide (Sigma) 
solution on each silk scaffold. These scaffolds were then placed in the bore in the 
septum of the co-culture well. In the two compartments separated by the septum, 
chondrogenic media was added in one, and osteogenic media was added in another and 
the scaffold was cultured for 2 weeks. (Compositions of chondrogenic media: high 
glucose DMEM supplemented with 10
-7
M dexamethasone, 1% ITS+ premix, 50mg/ml 
ascorbic acid, 1mM sodium pyruvate and 4mM proline. Chondrogenic differentiation 
was induced in the presence of 10 ng/ml Transforming Growth Factor β3 (TGF-β3) 
(R&D Systems, Minneapolis, MN), and osteogenic media: high glucose DMEM 
supplemented with 10% fetal bovine serum (FBS), 10
-7
M dexamethasone, 50 mg/ml 
ascorbic acid and 10nM β-glycerophosphate (Sigma)). Culture medium was changed 
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every 2 days. T Three control groups were used here. One control group was setup as 
chondrogenic control; chondrogenic medium was added in both chambers of the 
co-culture well. Similarly, in osteogenic control group, osteogenic medium was added 
in two chambers to culture the sample. For gene expression study, the last control 
group was a set of scaffolds seeded with BMSCs that were cultured in DMEM media 
supplemented with 10% FBS was used for reference analysis for all groups.  
 
Fig. 5-1 Osteochondral 3D co-culture system: A single well with 2 chambers for 
osteogenic & chondrogenic mediums and a 1.5 mm thickness centre septum with hole 
in the middle for scaffold placement. 
 
5.2.4. Scaffold diffusion analysis 
Two scaffold diffusion tests were done in this study. In the first test, scaffolds 
(n=5) without seeding cells were placed in the bore in the septum of the co-culture well. 
The thickness of scaffolds was measured and marked every 1.5 mm before use. 
1mg/ml FITC-BSA (Sigma) solution and distill water were added in two chambers. 
After 1, 24 and 48 hours, samples were harvested and sliced into three 1.5 mm 
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thickness pieces by scalpel, which named as Layer 1, 2 and 3. 5 µl solution was got 
from each pieces and diluted in 95 µl distill water and samples were read at 489 nm 
(TECAN Microplate Reader, Magellan Instrument, Control and Data Analysis 
Software) to obtain the concentration of FITC-BSA. Final result was got by compared 
with 1 mg/ml as percentage. In the second test, 0.5 million BMSCs were seeded with 
50µl of 0.5% RADA peptide (Sigma) solution on each silk scaffold. These scaffolds 
were then placed in the bore in the septum of the co-culture well. In the two 
compartments separated by the septum, high glucose DMEM medium with 10% FBS 
was added in one, and high glucose DMEM medium with 10% FBS, 10% Alamarblue 
(Invitrogen) was added in another and the samples were cultured for 1, 24 and 48 hours. 
Samples (n=5) were then harvested and washed with PBS for observation. Control 
group that added DMEM medium with 10% FBS in two compartments was served 
here. 
 
5.2.5. Total RNA extraction, cDNA synthesis, quantitative real-time PCR analysis 
and DNA electrophoresis 
     In the gene expression test, the zonal organization of osteochondral construct 
was investigated. After two weeks of culture in the  two-chambered co-culture well, 
samples from both the co-culture group and  control groups (n=3) were harvested. 
Samples from the co-culture wells were sliced into three 1.5 mm pieces (presumably 
the osteogenic region, middle region and chondrogenic region) by scalpel and tested. 
The details method of RNA extraction, cDNA synthesizing was presented in section 
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3.2.5 in Chapter 3. The primer sequences of selected genes for real-time PCR are 
summarized in Table 4-1 [102, 164, 189, 190]. GAPDH was used as the housekeeping 
gene and relative expression levels for each gene of interest were determined. For 
quantification analysis of the result, comparative Ct method (2
–ΔΔ
Ct) was use here 
[199]. Data from co-culture samples, chondrogenic control and osteogenic control were 
all normalized with samples that culture in common DMEM medium with 10% FBS to 
get the final results.  
Qualitative examination of the gene expression of Type I, II and X Collagen was 
carried out using gel electrophoresis. The DNA was obtained from the RT-PCR and 
analyzed using 1.5% agarose gel containing 0.5 mg/mL ethidium bromide (EtBr) Gel 
electrophoresis was run in the 1X TAE running buffer (40mM Tris-acetate, 1Mm 
EDTA) at 100V for 25 min in the Sub-Cell system (Bio-Rad Laboratories, CA). DNA 
bands were then observed by the UV transilluminator (UVP Inc, USA). 
 
5.2.6. Histology and Immunohistochemistry  
To investigate the differentiation of the BMSCs on different regions of the 
scaffolds, cell seeded scaffolds from the co-culture group were harvested after 2 weeks 
and fixed with 4% formaldehyde, dehydrated, embedded in paraffin and cut into 10 µm 
sections and stained with hematoxylin and eosin (H&E) for histological observation. 
Moreover, to further investigate the zonal organization of osteochondral constructs, 
special compositions in the ECM were also stained. Alizarin red staining was used here 
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to investigate the mineralization of ECM. To investigate the GAGs in the ECM, Alcian 
blue staining was used.  
To investigate ECM protein-type X produced by differentiated BMSCs, 
immunohistology staining was used on the cryomicrotome with a labelled 
streptavidin-biotin immunoenzymatic antigen detection system (UltraVision Detection 
System Anti-Mouse, HRP/DAB; LabVision, USA) [164, 198]. The method of staining 
was presented in section 3.2.8 in Chapter 3.  
 
5.2.7. Morphological characterization and Mineralization analysis  
Cell and ECM morphology in the cell-seeded scaffolds was also characterized 
using SEM. Harvested samples from the co-culture group after 2 weeks culture were 
washed with PBS thrice Samples were fixed in 4% formaldehyde and freeze dried for 
24 h, sputter-coated with gold and observed by SEM.  
To investigate mineralization of the construct, peripheral quantitative computed 
tomography (PQ-CT) was used in this study. For PQ-CT, 2 week old samples (n=3) 
were fixed in 3.7% formaldehyde for 24 hours and then analyzed by PQ-CT scanning to 
determine the mineralized tissue density. The analyses were carried out using 
StraTEC’s XCT software (Research SA+, StraTEC Medizintechnik, GmbH, and 
Pforzheim, Germany). Random areas in three regions were chosen to analyses the 
density of mineralization. A test view scan was performed prior to the actual scan to 




5.2.8. Statistical analysis 
All data were expressed as means ± standard deviation. Multiple comparisons 
were performed using one-way ANOVA and posthoc Tukey tests for pairwise 




5.3.1. Scaffold diffusion analysis 
After 1, 24 and 48 hours, significantly different concentrations of FITC-BSA 
were found in different layered of scaffolds (Fig. 5-2. A). From Layer 1 to Layer 3, 
the concentrations were: 97.7±3.1%, 50.9±1.7% and 0.8±0.7% for 1 hour, 93.1±3.3%, 
50.3±4.7% and 4.1±1.9% for 24 hours, 90.1%±7.0%, 47.5%±11.2% and 7.6%±3.8% 
for 48 hours. Layer 2 is the middle region of the scaffold; about half of the 
concentration was founded compared with Layer 1. In test two, samples were 
harvested in 1 hour, 24 hours and 48 hours time point. After washing with PBS, cells 
that were affected by Alamarblue appeared pink color (Fig. 5-2. B). When comparing 
24 hours samples with 48 hours samples, the pink coloration could be observed to 




Fig. 5-2 A) FITC-BSA diffusion analysis for scaffold without cells. (B) Alamarblue 
staining analysis. (i) Test group samples treated with Alamarblue dye in one chamber 
and DMEM medium in another chamber. (ii) Control group samples treated with 
DMEM medium in both chambers. 
5.3.2. q-RT-PCR analysis for gene expression  
The effect of the two-chambered co-culture well on transcription of chondrogenic, 
osteogenic and hypertrophic chondrogenic markers was examined in this study. After 2 
weeks culture, cells in three regions (osteogenic region, middle region and 
chondrogenic region) in the single scaffold showed different gene expression trends.  
For chondrogenic gene markers - Type II Collagen, Aggrecan and Sox-9, chondrogenic 
region showed the highest expression. Specially, the expression of Type II Collagen 
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and Aggrecan were more than 10 and 2 fold significantly higher respectively as 
compared to the middle and osteogenic regions (p<0.05). In contrast, Runx-2 and 
Osteopotin showed significantly higher expression in the osteogenic region (p<0.05). 
The expression of Type I Collagen in the middle region was slightly higher than the 
remaining two regions, however, the difference were not significant (p>0.05). Two 
markers of chondrogenic hypertrophy Type X Collagen and MMP-13 were also used in 
this study. From the results obtained, the middle region showed the significantly 
highest Type X Collagen expression in these three genes (p<0.05). The results from the 
agarose gel electrophoresis showed Type I, II and X Collagen genes could be found in 
all the three regions. Type II Collagen was expressed more strongly in the 
chondrogenic and middle regions, whereas Type I Collagen was found to be expressed 
more strongly in the osteogenic and middle regions. However, Type X Collagen 
showed significant higher expression only in the middle region of the co-culture 
samples than all the rest samples. Chondrogenic /osteogenic control (Ch-C, Os-C) were 
used in this study. The expression of markers show in table  
 Col II Agg Sox-9 Col I  Osteopotin Runx-2 Col X MMP-13 
Ch-C 256.5±16.6 144.9±26.4 5.2±1.6  2.1±0.3 27.3±0.5  1.6±0.3 4.2±0.2 3.1±1.9 
Os-C  10.1±1.2 27.9±7.8 1.5±0.3 14.3±4.0 153.8±45.8 9.3±1.1 4.8±1.3 6.4±0.7 




When chondrogenic region compared with chondrogenic control, there was no 
significant difference in all genes expression except the Type II Collagen. The 
expression of Type II Collagen in chondrogenic region from co-culture samples was 
significantly higher than chondrogenic control (p<0.05). When compared between 
osteogenic control and osteogenic region from co-culture samples, significant higher 





Fig. 5-3 (A-H) Gene expression analysis: normalized expression levels of 
chondrogenic, osteogenic and hypertrophy-related genes in osteogenic region, middle 
region and chondrogenic region from co-culture group compared with control group 
after 2 weeks of co-culture. (I) Agarose gel electrophoretic images of Type Collagen I, 
II and X DNAs. 
 
5.3.3. Cell morphology  
After 2 weeks of static culture in the two-chambered co-culture well, the cells 
distribute throughout and adhere to the entire scaffold. Under the two chambers’ 
different chemical stimulation, HE staining showed that cells displayed three distinct 
morphologies in the three regions (Fig. 5-4). In the osteogenic region, cells were 
distributed well in this region. In contrast, a spherical chondrocyte-like morphology 
could be found in the middle region. Finally, a smaller spherical chondrocytes could 
be found in the chondrogenic region. In chondrogenic control group and osteogenic 
control group, similar spherical chondrocytes cells and osteoblasts like cells could be 





Fig. 5-4 H&E histology analysis of three regions of osteochondral constructs cultured 
after 2 weeks showing that different cell morphologies in three regions on co-cultured 
osteochondral constructs (indicated by arrows). Silk scaffold (S) could also be observed. 
(A-C) (Scale bar=200 µm); (D-F) (Scale bar=50 µm). (A, D) Osteogenic region; (B, E) 
Middle region; (C, F) Chondrogenic region.  
 
5.3.4. Mineralization, GAG and Collagen deposition in multilayered ECM by 
using two chambered co-culture well 
Alizarin Red staining results (Fig. 5-5) showed that the highest amount of calcium 
was deposited in the osteogenic region and osteogenic control; and a few calcium 
deposits could also be stained in the middle region. However, as compared to the 
osteogenic part, little calcium was stained in the chondrogenic region and 
chondrogenic control. SEM and PQ-CT results all confirmed this finding. In 
osteogenic control, osteogenic region and the middle region, a number of 0.1-1 um 
mineralized particles (Fig. 5-6 arrow point) were observed on the surface of the 
scaffold and the ECM, and more particles can be found in the osteogenic region and 
osteogenic control. In addition, quantitative analyses further indicated a gradation in 
the mineral deposition across the various zones of the scaffold. The PQ-CT (Fig. 5-7) 
results suggested that in the osteogenic region, the highest density of mineralization 
was present; it was found to be 3 fold significantly higher than the chondrogenic 
region respectively and the density of mineralization in middle region was also 




Fig. 5-5 Histology analysis of the osteochondral constructs co-cultured for 2 weeks 
showing that Alizarin red positive staining could be observed in Osteogenic region and 
Middle region. Alcian blue positive staining could be observed in Middle and 
Chondrogenic region. Type collagen X could be found higher in Middle region than the 
other two parts (A-C) Alizarin red staining; (D-F) Alcain blue staining;  (G-I) 
Immuno-staining for Type X Collagen.  (A, D G) Osteogenic region; (B, E, H) Middle 
region; (C, F, I) Chondrogenic region); (Scale bar = 500µm).  
 
In contrast, the Alcian blue staining showed that higher amount of GAG was 
distributed in the chondrogenic control, chondrogenic region and middle region, as 
compared to the oesteogenic region and osteogenic control. Immuno-staining analyses 
for Type X Collagen of the multilayered co-culture osteochondral constructs were 
performed. From the results (Fig. 5-5) Type X Collagen was only slightly stained in 





Fig. 5-6 SEM images for cell and ECM morphology analysis. (A-C) (Scale bar=100 
µm), (D-F) (Scale bar=20 µm); (A, D) Osteogenic region; (B, E) Middle region. (C, F) 
Chondrogenic region. The particles of mineralization on ECM in Osteogenic region 




Fig. 5-7 (A) Peripheral quantitative computed tomography evaluation of osteochondral 
samples by co-cultured for 2 weeks; (B) Quantitative of mineral density Of osteogenic 





The main objective of osteochondral tissue engineering is to engineer the entire 
osteochondral tissue with cartilage layer, intermediate calcified cartilage layer and the 
subchondral bone layer [180, 195]. Chondrocytes are the main cell source for 
osteochondral tissue generation. However, harvesting chondrocytes may cause an 
unrecovered injury to patients and chondrocytes also have dedifferentiated issues 
when expansion culture [95]. On the other hand, the bone marrow stromal cells have 
been reported to possess the ability to differentiate into chondrocytes or osteoblasts 
and are thus, capable of generating new osteochondral or bone tissue [200, 201].  A 
recent method for the formation of an osteochondral multilayer has been reported by 
Cheng, et al. In their study, pre-differentiated osteogenic and chondrogenic BMSCs 
were used to induce hypertrophic chondrocyte differentiation to form the multilayered 
structure in vitro [29]. From the results of our study, we provide another possible 
method using only BMSCs as the cell source, to engineer a multilayered 
osteochondral construct without pre-differentiation processes, thus enabling a 
single-step procedure.  
In this study, rabbit derived bone marrow stromal cells (BMSCs) were seeded in a 
bio-inspired 3D silk/RADA peptide hydrogel hybrid scaffold. From the scaffold 
diffusion result, layered different stimulations could be provided by the co-culture 
well. We used this model to investigate the potential of BMSCs as a single cell source 
by using the specially designed co-culture well, which provides both chondrogenic 
and osteogenic stimulation in different zones of BMSCs in the scaffold for 
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multilayered osteochondral construct formation and functional interface generation. 
This co-culture approach stably facilitated BMSC proliferation, production/deposition 
of collagen and modulation of gene expression of various marker genes in 
multilayered osteochondral constructs. The interface-specific ECM proteins, 
suggesting the differentiation of middle region’s BMSC into hypertrophic 
chondrocyte phenotype. Moreover, multilayered osteochondral constructs were 
successfully generated by this co-culture system. 
The results showed that the BMSCs in different zones of the scaffold committed 
to differentiation in different pathways. The quantitative RT-PCR results confirmed 
the differentiation. In the chondrogenic region, Type II Collagen and Aggrecan were 
significantly higher (p<0.05) than the middle region and the osteogenic region. In 
contrast, in the osteogenic region, Runx-2 and Osteopotion were significantly higher 
than the chondrogenic region (p<0.05). In the osteogenic region and middle region, 
the expression of Type I Collagen was not significantly different but both were 
significantly higher (p< 0.05) than the chondrogenic region. Moreover, the highest 
expression of Type X collagen, MMP-13 could be observed in the middle region; 
these being considered hypertrophic chondrogenic markers [66, 202]. From Cheng’s 
report, the osteogenic and chondrogenic BMSCs can induce the hypertrophic 
chondrogensis differentiation for BMSCs [29]. In our study, chondrogenic and 
osteogenic differentiation was induced by two type of medium supplying in the two 
top regions of the scaffold. Thus, these two kinds of differentiated BMSCs have the 
potential to induce the BMSCs hypertrophic differentiation in the middle region. In 
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addition, the mix of mediums in middle region could further improve hypertrophic 
differentiation and ECM mineralization. TGF-β3 has been proven its chondrogenic 
stimulated ability for BMSCs [203-205]; however, the presence of 
β-glycerophosphate and reduce the concentration of TGF- β3 in the middle region 
might cause hypertrophy chondrocytes produce more Type Collagen X and form the 
mineralized ECM [153]. 
When comparing with osteogenic control, most of gene expressions in osteogenic 
region were no significantly difference. Only the MMP-13 was found significantly 
higher (p<0.05) expression in osteogenic region. MMP-13 is expressed in the skeleton 
tissue as required for restructuring the collagen matrix for ECM mineralization and 
chondrogenic hypertrophic [206]. In this study, the osteogenic region from co-culture 
might be still in higher mineralization progress than osteogenic control. Another 
possible reason is that the osteogenic region was cut depended on thickness from the 
co-culture sample; some hypertrophic chondrocytes might locate in this region. 
Similarly, when comparing with chondrogenic control, all gene expression in 
chondrogenic region was similar, except the chondrogenic region have even higher 
Type II Collagen expression. Hypertrophic chondrocytes are the main cell type in the 
osteochondral interface region and have a larger size than normal chondrocytes [29, 
62]. By comparing with control groups and different regions form co-culture sample, 
results all proved that the co-culture approach can truly introduce the differentiation 
of BMSCs into chondrogenic, osteogenic and hypertrophic chondrogenic cell lineage 
simultaneously. From the results of H&E staining, totally different cell morphologies 
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could be observed in the three regions. Although cells in both the middle region and 
the chondrogenic region were of spherical morphology, larger cell size could be found 
in middle region.  
Osteochondral tissue is multilayered in nature [12, 207]. Beside different types of 
cells distributed in the multilayered structure, the ECM compositions are also 
arranged in layers [62, 180, 208]. The osteochondral interface has a transitional ECM, 
which has high density of GAG, Type I, II and X Collagen. Moreover, it is a 
mineralized ECM [195, 209]. In this study, results from histological examination 
suggested that layered distribution of GAG and calcium in ECM could be observed in 
co-culture samples; however, the layered boundary was not very obvious. In the 
chondrogenic region and chondrogenic control, cells with spherical morphology 
chondrocyte were embedded in a GAG-rich and un-mineralized ECM. In contrast, in 
the osteogenic region and osteogenic control, star shaped osteoblast morphology cells 
were embedded in a mineralized ECM with high density of calcium. However, a 
GAG rich and mineralized ECM could be found in middle region. Moreover, Type X 
Collagen was found to have the highest density in this region.  In addition, the SEM 
analyses and pqCT also confirmed this finding; specially, they showed that the 
differential distribution of mineralization in the whole construct. Thus, besides the 
different gene expression, this co-culture approach could also generate a multilayered 
ECM structure that mimicked the native osteochondral tissue. All these above results 
showed that this co-culture system has the potential to generate a multilayered 





) by this engineered plug, which can solve the donor shortage issue in 
conventional methods, such as autograft [210]. For even larger size defects treatment, 
mosaicplasty method can be used to implant several engineered plugs together.  
There are still some limitations in this study. First of all, our aim is to engineer a 
multilayered osteochondral construct that has three main layers. However, our 
co-culture well can provide only chondrogenic and osteogenic stimulation 
simultaneously and some unwanted diffusion might cause high Type I Collagen 
production in chondrogenic region. To further improve our work, the ability to 
provide hypertrophic chondrogenic stimulation may aid the formation of an improved 
3 layered osteochondral construct or a better and precise controllable system that can 
decrease the unwanted diffusion are required to improved the better layered structure 
arrangement. Secondly, although we successfully differentiated the BMSCs to 
hypertrophic chondrocytes in the middle region, the mechanism of the stimulation is 
still unclear. Therefore, it is necessary to find out whether the stimulation comes from 
the media or/and neighbouring differentiated chondrogenic/osteogenic BMSCs.  
 
5.5. Concluding remarks 
Results in this study demonstrated that this co-culture approach could successfully 
provided rabbit BMSCs in different zones of the scaffold to result in the formation of 
multilayered osteochondral constructs with cartilage, subchondral bone tissue, as well 
as the osteochondral interface in 2 weeks culture in vitro. Cells in the intermediate 
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region could be differentiated into hypertrophic chondrocytes, which were embedded 
in a calcified ECM with rich glycosaminoglycans, Type Collagen Type I, II and X. 
Above all, the results of this study provided a possible one-step approach supporting 
the choice of BMSCs as a single cell source for multilayered osteochondral construct 
regeneration without pre-differentiated process in vitro, which provide another 












Stage 4: Design and fabricate a three-chambered co-culture 
bioreactor and the effectiveness of hypertrophic chondrogenic 
stimulation medium 
 
6.1. Introduction  
Physiological osteochondral calcified cartilage layered between cartilage and 
subchondrol bone regeneration is a significant challenge. Although the exact elements 
to differentiate stem cells into hypertrophic chondrocytes are still unknown, bioactive 
factors have been shown to be important for osteochondral tissue generation [51, 211]. 
Through recent cartilage and bone tissue engineering strategies, various stimulated 
factors have been shown to be necessary and important in improving the cell 
proliferation, stromal cells differentiation and keeping cell morphology in vitro 
[212-214]. Transforming growth factor beta 3 (TGF-β3) is a member of the 
Transforming growth factor beta superfamily. TGF-β has not only been shown to have 
the ability to improve cell adhesion and ECM production, but also has the potential to 
induce BMSCs chondrogenic differentiation. On the other hand, β-glycerophosphate, 
a common composition for osteogenic differentiation, has been shown that it can 
induce ECM mineralization and chondrogenic hypertrophy [215]. This step of work 
firstly aimed to investigate the effects of a special hypertrophic chondrogenic 
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stimulation media (HCM) on the hypertrophic chondrogenic differentiation of bone 
marrow stromal cells (BMSCs) in vitro. 
In order to carry out this study, a bioreactor that could provide 3 kinds of 
mediums, which included chondrogenic medium, hypertrophic chondrogenic medium 
and osteogenic medium, was designed and fabricated. Validity of inducing 
osteochondral tissue generation of this novel approach was also tested by silk/peptide 
with BMSCs, resulting in the formation of multilayered osteochondral constructs 
containing cartilage-like and subchondral bone-like tissue and the intermediate 
osteochondral interface. The whole constructs were evaluated using gene expression, 
structural, histological and mechanical tests for multilayered organization.  
 
6.2. Materials and methods 
6.2.1. Scaffold preparation  
Bombyx mori silk fibers were used in this study. Raw silk fibers were immersed 
in a degumming solution of 0.25% (w/v) Na2CO3 and 0.25% (w/v) sodium dodecyl 
sulfate (SDS) between 98°C and 100°C. After 30 minutes, the solution was refreshed. 
This process was repeated until the sericin was removed. The degummed silk was 
rinsed with distilled water for 1 hour to remove the residual degumming solution 
before leaving it to air dry. The degummed silk then was dissolved in a mixture of 
calcium chloride, ethanol and water (CaCl2–CH3CH2OH–H2O) (molar ratio = 1:2:8) 
at 65°C with continuous stirring. The resulting silk solution was dialyzed against 
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distilled water using a SnakeSkin Pleated Dialysis Tubing (PIERCE, MWCO 3500). 
The concentration (w/v) of the dialyzed solution was determined and adjusted to 3% 
w/v using distilled water. The silk solution was transferred into Petri dishes and frozen 
at -20°C, followed by freeze drying for 24 hours. Freeze dried silk sponge scaffolds 
were fixed in 90% methanol for 10 minutes, and then rinsed with distilled water. The 
final scaffold was 5 mm diameter and 6 mm thickness.  
 
6.2.2. Effectiveness of hypertrophic chondrogenic medium (HCM) for generation 
of the osteochondral interface 
6.2.2.1. 2D and 3D model  
Bone marrow-derived stromal cells (BMSCs) were obtained from New Zealand 
White Rabbits using a previously described protocol approved by the NUS 
Institutional Animal Care and Use Committee, National University of Singapore [216]. 
Passage 2 BMSCs were used in all tests in this study. 10,000 BMSCs were seeded in 
24 well cell plate (3ml; Cellstar, Greiner Bio-One). 500 μl of Dulbecco’s Modified 
Eagle’s Medium (DMEM)-low glucose (LG) containing 15% fetal bovine serum 
(FBS), 1% penicillin and streptomycin was added to each well and cells cultured for 1 
day in a 5% CO2 incubator at 37
o
C for cell adherence. After cell adherence, the 
medium in each well was changed to HCM ( DMEM-high glucose (HG) with 5% 
FBS, 10
-7M dexamethasone (Sigma), 50μg/ml ascorbic acid (Sigma), 5mM 
b-glycerophosphate and 1% penicillin and streptomycin (Gibco) 0.5% ITS+ premix 
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(BD), 0.5 mM sodium pyruvate (Gibco), 0.2mM proline (Sigma), 1mM L-Glutamine 
(Gibco). 5ng/ml Transforming Growth Factor-Beta 3 (TGF-β3) was included before 
use) and cultured for 2 weeks. In this study, groups using Osteogenic medium only 
and Chondrogenic medium only served as controls.  Osteogenic medium (OM) was 
made by mixing DMEM-high glucose (HG) with 10% FBS, 10
-7
M dexamethasone 
(Sigma), 50μg/ml ascorbic acid (Sigma), 10mM b-glycerophosphate and 1% 
penicillin and streptomycin (Gibco). Chondrogenic medium (CM) was made up of 
DMEM-HG, 10
-7M dexamethasone (Sigma), 1% ITS+ premix (BD), 50μg/ml 
ascorbic acid (Sigma), 1mM sodium pyruvate (Gibco), 0.4mM proline (Sigma), 1% 
penicillin and streptomycin (Gibco), 2mM L-Glutamine (Gibco). 10ng/ml 
Transforming Growth Factor-Beta 3 (TGF-β3) was also included before use.  
In the 3D study, 1 million passage 2 BMSCs were suspended in 50 µl of 0.5 % 
(w/v) RADA peptide in 295mM sucrose solution and seeded in silk sponge. Fresh 
DMEM medium containing 15% FBS was used to allow self-assembly of the peptides 
for hydrogel in silk sponge for 2 h. The scaffolds with cells were then transferred into 
24 culture wells for chondrogenic hypertrophic culture by HCM for 2 weeks, similarly, 
OM and CM were served as control.  
 
6.2.2.2. Total RNA extraction, cDNA synthesis, and real-time RT-PCR analysis 
Gene expression for various osteogenic, chondrogenic and hypertrophic markers 
were analyzed after 2 weeks of treatment to evaluate the differentiation of the seeded 
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BMSCs both in 2D and 3D model. For 2D samples, cells from wells (n=3) of each 
group were collected for RNA extraction. For 3D samples, scaffolds with cells were 
collected and rinsed in PBS before total RNA was extracted using a RNeasy Mini Kit 
(Qiagen, USA) following the supplier’s protocol. The final eluted RNA was reverse 
transcribed to cDNA using iScript cDNA synthesis Kit (BioRad). Real-time RT-PCR 
was performed in a real-time RT-PCR machine (iQ5 Multicolor Real-time PCR 
Detection System) using the iQ Green RT-PCR Kit (Qiagen, USA). Assays were run 
in triplicates for each sample. The primer sequences of selected genes for real-time 
PCR were summarized in Table 4-1 [102, 166, 168, 217]. GAPDH was used as the 
housekeeping gene and relative expression levels for each gene of interest were 
determined. 
 
6.2.2.3. Histology  
After 2 weeks of treatment, Alizarin Red staining and Alcian Blue staining were 
performed in 2D model. Alizarin Red was used to stain for osteogenic-specific 
calcium and Alcian Blue was used to stain for cartilage matrix-specific sulfated GAG. 
Briefly, the samples from each 2D group were first washed with PBS and fixed using 
2ml of precooled methanol (Merck, Germany) in a -20°C fridge for 5mins to fix. Then, 
Alizarin red staining and Alcian Blue staining were done.  
In 3D samples, Histological examination of cell seeded scaffolds after 14 days of 
culture was performed. Scaffolds were harvested and fixed with 3.7% formaldehyde, 
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dehydrated, embedded in paraffin with 10µm sections cut from each sample and 
stained with hematoxylin and eosin (H&E) for histological observation. Similarly, 
Alizarin Red staining and Alcian Blue were also performed here.  
 
6.2.3. Fabrication of three-chambered Bioreactor  
The purpose of the three-chambered bioreactor was to provide different chemical 
stimulation to BMSCs seeded on the various layered regions on the scaffold. To 
achieve this, the tissue chamber and components of the bioreactor system in contact 
with medium were made of biocompatible and sterilizable materials. Polycarbonate 
was chosen for fabricating the culturing wells of the bioreactor. Each well contained 
two polycarbonate septum fixed vertically in the middle of the well and separated the 
wells into 3 chambers. A hole of diameter 4.5 mm was provided in the septums for the 
horizontal placement of a BMSC seeded silk/peptide scaffold. Osteogenic and 
chondrogenic stimulation media could each be placed in the 3 compartments 
separated by the septum to introduce the BMSCs to osteogenic, chondrogenic and 
hypertrophic differentiation on different layers of single scaffold simultaneously. The 
whole system was designed as for medium to flow in one direction without 
recirculation. Mediums were changed every 3 hours automatically by two peristaltic 




Fig. 6-1 Design of the three-chamber co-culture bioreactor: three-chamber co-culture 
chamber is feeded by three kinds of mediums ( Chondrogenic, osteogenic and cocktail 















6.2.4. Scaffold diffusion analysis 
In this test, scaffolds (n=5) without cells were placed in the bore of the septums 
in the assembled three-chambered wells. The thickness of scaffolds was measured 
and marked at every 2 mm intervals before use. 1mg/ml FITC-BSA (Sigma) solution, 
0.5 mg/ml FITC-BSA and distilled water were added in each of the three chambers. 
After 10 mins, 20 mins, 30 mins, 1h, 2h, 3h and 4 h, samples were harvested and 
sliced into three 2 mm thickness pieces by scalpel and the pieces soaked in distilled 
water were taken for analysis. 5 µl solution was obtained from these pieces and 
diluted in 95 µl distill water and samples were read at 489 nm (TECAN Microplate 
Reader, Magellan Instrument, Control and Data Analysis Software) to obtain the 
concentration of FITC-BSA. Final result was obtained by comparing with 1 mg/ml as 
percentage.  
 
6.2.5. Cell seeding and culture in three-chambered bioreactor 
Passage 2 BMSCs were used in all tests in this study. 1 million BMSCs were 
seeded with 50µl of 0.5% RADA peptide (Sigma) solution on each silk scaffold. These 
scaffolds were then placed in the bore of the septums in the three-chambered well. In 
the three compartments separated by the septums, hypertrophic chondrogenic medium 
was added into the middle compartment while chondrogenic media and osteogenic 
media were separately added into the side compartments. The scaffold was cultured 
for 2 weeks. (Composition of three mediums was mentioned above). Culture medium 
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was changed every 3 hours automatically. Two control groups were used here. One 
control group was set up as chondrogenic control; chondrogenic medium was added in 
three chambers of the well. Similarly, in osteogenic control group, osteogenic medium 
was added in three chambers to culture the samples.  
 
6.2.6. Total RNA extraction, cDNA synthesis, quantitative real-time PCR analysis 
and DNA electrophoresis 
In the gene expression test, the zonal organization of osteochondral construct was 
investigated. After two weeks of culture in the three-chambered co-culture well, 
samples from both the co-culture group and control groups (n=3) were harvested. 
Samples from the co-culture wells were sliced into three 2 mm pieces (presumably the 
osteogenic region, middle region and chondrogenic region) by scalpel and tested. All 
samples for the gene expression study were rinsed with PBS; total RNA was extracted 
using an RNeasy Mini Kit (Qiagen, USA) following the supplier’s protocol. The final 
eluted RNA was stored at -20°C and reverse transcribed to cDNA using iScript cDNA 
synthesis Kit (BioRad). Real-time RT-PCR was performed in a real-time RT-PCR 
machine (iQ5 Multicolor Real-time PCR Detection System) using the iQ Green 
RT-PCR Kit (Qiagen, USA). Assays were run in triplicates for each sample. The primer 
sequences of selected genes for real-time PCR are summarized in Table 6-1[102, 164, 
189, 190]. GAPDH was used as the housekeeping gene and relative expression levels 
for each gene of interest were determined. For quantification analysis of the result, 
comparative Ct method (2
–ΔΔ




6.2.7. Histology for bioreactor cultured samples 
To investigate the differentiation of the BMSCs on different regions of the 
scaffolds, cell seeded scaffolds from the co-culture group were harvested after 2 weeks 
and fixed with 4% formaldehyde, dehydrated, embedded in paraffin and cut into 10 µm 
sections and stained with hematoxylin and eosin (H&E) for histological observation. 
Moreover, to further investigate the zonal organization of osteochondral constructs, 
special compositions in the ECM were also stained. Alizarin red staining was used here 
to investigate the mineralization of ECM. To investigate the GAGs in the ECM, Alcian 
blue staining was used.  
To investigate ECM protein-type X produced by differentiated BMSCs, 
immunohistology staining was used on the cryomicrotome with a labelled 
streptavidin-biotin immunoenzymatic antigen detection system (UltraVision Detection 
System Anti-Mouse, HRP/DAB; LabVision, USA) [164, 198]. Briefly, the rehydrated 
sections were digested enzymatically with pepsin (1 mg/mL) for 30 min at RT, and then 
incubated with a mouse anti-pig monoclonal antibody (Sigma,USA). After that the 
horseradish peroxidase (HRP) labeled secondary antibody was used. Finally, all 
sections were covered by coverslips using permanent mounting medium. 
6.2.8. SEM analysis 
Cell and ECM morphology in the cell-seeded scaffolds was also characterized 
using SEM. Harvested samples from the co-culture group after 2 weeks’ culture were 
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washed with PBS thrice Samples were fixed in 4% formaldehyde and freeze dried for 
24 h, sputter-coated with gold and observed by SEM.  
 
6.2.9. Mechanical analysis  
   Compressing biomechanical testing was performed on the cell-seeded scaffolds, 
using a universal testing machine (Instron 3345 Tester, Instron, Norwood, MA). After 
two weeks of culture in the three-chambered co-culture well, samples from both the 
co-culture group and control groups (n=4) were harvested. All samples were sliced into 
three 2 mm pieces (presumably the osteogenic region, middle region and chondrogenic 
region) by scalpel and fixed by 4% formaldehyde and freeze dried for 24 h. Unseeded 
scaffolds that had been similarly incubated in culture media for 2 weeks were also 
tested as an additional control. Followed by the vendor’s protocol, maximum stress of 
samples can be sustain under crush loading or equal compressed distance. Samples 
were placed on support platform and attached the sensor of load cells (Max load: 
10N). In this study, the scaffold cannot be crushed, thus samples were compressed by 
1mm by the speed of 0.2 mm/ min. The max compressing load was recorded and 
compared. 
 
6.2.10. Statistical analysis 
All data were expressed as means ± standard deviation. Multiple comparisons 
were performed using one-way ANOVA and posthoc Tukey tests for pairwise 
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comparisons (SPSS 13.0 software package). p < 0.05 was accepted as statistically 
significant. 
 
6.3. Results  
6.3.1. Effectiveness of hypertrophic chondrogenic medium (HCM) 
6.3.1.1. Q-RT-PCR analysis for gene expression of osteochondral interface 
specific ECM Proteins 
The effect of HCM of both chondrogenic, osteogenic and hypertrophic 
chondrogenic markers was examined in this study. In the first gene test, samples were 
cultured by three stimulation mediums, the expression of Aggrecan and Type II 
Collagen was significantly highest in chondrogenic control group after 2 weeks 
culture (p<0.05, Fig. 6-4 ).  In contrast, Type I Collagen and MMP-13 gene 
expression was significantly highest in osteogenic control group. In this study, Type X 
collagen expression was found only in the co-culture group. Similarly, MMP-13 was 
found significantly lowest expression in three groups.  
In the second gene test, samples were cultured by three stimulation mediums. 
Similarly, the expression of Aggrecan and Type II Collagen was significantly highest 
in chondrogenic control group after 2 weeks culture (p<0.05, Fig. 6-5). Type I 
Collagen and RUNX-2 gene expression was lowest in chondrogenic control group. In 
3D model study, Type collagen X and MMP-13 expressions were found more than 2 






Fig. 6-4 Gene expression study one: 2D model samples cultured by chondrogenic, 
osteogenic and hypertrophic chondrogenic medium for 2 weeks. All gene expression 






Fig. 6-5 Gene expression study two: 3D model samples cultured by chondrogenic, 
osteogenic and hypertrophic chondrogenic medium for 2 weeks. All gene expression 
was normalized by comparison with housekeeping gene GAPDH. (*,p< 0.05)  
 
6.3.1.2. ECM composition and cell morphology assay  
Alizarin Red staining results for 2D study (Fig. 6-6) showed that the highest 
amount of calcium was deposited in the osteogenic control; and a few calcium 
deposits could also be stained in the HCM group. However, no calcium was stained in 
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the chondrogenic control. In contrast, the Alcian blue staining showed that higher 
amount of GAG was distributed in the chondrogenic control and HCM group, as 
compared to the osteogenic control.  
Fig. 6-6 Histology analysis of 2D model samples cultured by chondrogenic, osteogenic 
and hypertrophic chondrogenic medium for 2 weeks, showing that Alizarin red positive 
staining could be observed in Osteogenic control and HCM group. Alcian blue positive 
staining could be observed in HCM group and Chondrogenic control.  (Scale bar = 
200µm).  
 
In 3D samples, HE staining showed that cells distributed well in whole samples. 
Star-shaped osteoblast like cells could be observed in the osteogenic control. In 
contrast, a spherical chondrocyte-like morphology could be found in the HCM group. 
Finally, a smaller spherical chondrocytes cells could be found in the chondrogenic 
control. Similarly, Alizarin Red staining results for 3D study showed that the highest 
amount of calcium was deposited in the osteogenic control; however, no calcium was 
stained in the HCM group and chondrogenic control. In contrast, the Alcian blue 
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staining showed that higher amount of GAG was distributed in the chondrogenic 
control and HCM group, as compared to the osteogenic control.  
 
 
Fig. 6-7 Histology analyses of 3D model samples cultured by chondrogenic, osteogenic 
and hypertrophic chondrogenic medium for 2 weeks. H&E histology analysis (A-F) 
showing that different cell morphologies in three regions on co-cultured osteochondral 
constructs. Alizarin red positive staining could be observed in Osteogenic control. 
Alcian blue positive staining could be observed in HCM group and Chondrogenic 
control.  (A-C, G-L Scale bar = 200µm) (D-F scale bar = 50 µm ) 
 
6.3.2. Scaffold diffusion analysis by using three-chambered wells 
After 10 mins, 20 mins, 30 mins, 1 hour, 2 hours 3 hours and 4 hours, the 
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concentration of FITC-BSA was increased over time (Table. 6-2).  
 
10 min 20 min 30 min 1 h 2 h 3 h 4 h 
0 0.05% 0.05% 0.18% 0.31% 1.86% 3.4% 
Table 6-1 Scaffold diffusion by using 3 chambered wells 
 
6.3.3. q-RT-PCR analysis for gene expression  
The effects of the three-chambered bioreactor on transcription of chondrogenic, 
osteogenic and hypertrophic chondrogenic markers were examined in this study. After 
2 weeks culture, cells in three regions (osteogenic region, middle region and 
chondrogenic region) in the single scaffold showed different gene expression trends. 
For chondrogenic gene markers - Type II Collagen, Aggrecan and Sox-9, chondrogenic 
region showed the highest expression. Specifically, the expression of Type II Collagen 
was more than 2. 6 and 54 fold significantly higher respectively as compared to the 
middle and osteogenic regions (p<0.05). Similarly, Aggrecan in chondrogenic region 
was more than 2 and 6 fold significantly higher respectively as compared to the middle 
and osteogenic regions (p<0.05). In contrast, Runx-2 showed significantly higher 
expression in the osteogenic region (p<0.05). The expression of Type I Collagen and 
Osteonectin in the osteogenic region was slightly higher than the remaining two 
regions, however, the difference between osteogenic region and middle region was not 
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significant (p>0.05). Two markers of chondrogenic hypertrophy Type X Collagen and 
MMP-13 were also used in this study. From the results obtained, the middle region 
showed the significantly highest Type X Collagen expression in these three genes 
(p<0.05) and MMP13 was significantly higher than chondrogenic region. 
Chondrogenic /osteogenic controls (Ch-C/Os-C) were used in this study. The 
expressions of gene markers show in Table 6-3. 
 
 Col II Agg Sox-9 Col I  Osteopotin Runx-2 Col X MMP-13 
Ch-C 89.1±22.0 13.9±4.6 1.3±0.4  47.5±5.3 21.4±3.4  0.8±0.3 0.3±0.0 5.2±1.1 
Os-C  0.5±0.2 1.7±0.4 0.3±0.2 93.1±6.9 48.8±5.0 1.4±0.5 0.4±0.1 13.5±0.6 
Table 6-2 Gene expressions for chondrogenic control and osteogenic control. 
 
When chondrogenic region was compared with chondrogenic control, there was 
no significant difference in all genes’ expression except for Aggrecan. The expression 
of Aggrecan in chondrogenic region from co-culture samples was significantly lower 
than chondrogenic control (p<0.05). When comparing between osteogenic control and 
osteogenic region from co-culture samples, no significant difference in all genes’ 




Fig. 6-8 Gene expression analysis: normalized expression levels of chondrogenic, 
osteogenic and hypertrophy-related genes in osteogenic region, middle region and 
chondrogenic region from co-culture group compared with control group after 2 weeks 
of co-culture. 
 
6.3.4. Cell morphology  
After 2 weeks of culture, the cells distribute throughout and adhere to the entire 
scaffold. Under the three chambers’ different chemical stimulation, HE staining 
showed that cells displayed three distinct morphologies in the three regions (Fig. 6-9). 
Star-shaped osteoblast-like cells could be observed in the osteogenic region (Fig. 6-9 
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A) and the cells were distributed well in this region. In contrast, a spherical 
chondrocyte-like morphology could be found in the middle region and chondrogenic 
region (Fig. 6-9 B, C). In chondrogenic control group and osteogenic control group, 
similar spherical chondrocytes cells and osteoblasts like cells could be found.  
 
Fig. 6-9 H&E histology analysis of three regions of osteochondral constructs cultured 
after 2 weeks showing that different cell morphologies in three regions on co-cultured 
osteochondral constructs could also be observed. (Scale bar=100 µm); (A) Osteogenic 
region; (B) Middle region; (C) Chondrogenic region; (D) Osteogenic control; (E) 
Chondrogenic control.  
 
6.3.5. Mineralization, GAG deposition in multilayered ECM by using 
three-chambered bioreactor 
Alizarin Red staining results (Fig. 6-10) showed that the highest amount of 
calcium was deposited in the osteogenic region and osteogenic control; and a few 
calcium deposits could also be stained in the middle region. However, as compared to 
the osteogenic part, little calcium was stained in the chondrogenic region and 
chondrogenic control. SEM results confirmed this finding. In osteogenic control, 
 124 
 
osteogenic region and the middle region, a number of 0.1-1 um mineralized particles 
(Fig. 6-11-1 arrow point, Fig. 6-11-2 and Fig. 6-11-3) were observed on the surface of 
the scaffold and the ECM, and more particles could be found in the osteogenic region 
and osteogenic control. Besides, collagen fibres were found in osteogenic region and 
osteogeic control samples (Fig. 6-11-2).  In addition, quantitative analyses further 




Fig. 6-10 Histology analysis of the osteochondral constructs co-cultured for 2 weeks 
showing that Alizarin red positive staining could be observed in Osteogenic region, 
Middle region and Osteogenic control. (Scale bar = 50µm). (A) Osteogenic region; (B) 






Fig. 6-11-1 SEM images for cell and ECM morphology analysis. (A-C) (Scale bar=50 
µm), (D-F) (Scale bar=20 µm); (A, D) Osteogenic region; (B, E) Middle region. (C, F) 
Chondrogenic region. The particles of mineralization on ECM in Osteogenic region 




Fig. 6-11-2 SEM images for cell and ECM morphology analysis. (A-B) (Scale bar=50 









Fig. 6-11-3 SEM images for mineralized particulars and collagen fibers in osteogenic 
region. 
 
In contrast, the Alcian blue staining showed that higher amount of GAG was 
distributed in the chondrogenic control, chondrogenic region and middle region, as 
compared to the osteogenic region and osteogenic control (Fig. 6-12). 
 
Fig. 6-12 Histology analysis of the osteochondral constructs co-cultured for 2 weeks 
showing that Alcian blue positive staining could be observed in Middle and 
Chondrogenic region in co-culture samples and chondrogenic control. (Scale bar = 
100µm). (A) Osteogenic region; (B) Middle region; (C) Chondrogenic region; (D) 




6.3.6. Mechanical properties 
After two weeks of culture, significant difference of compressive loads were 
found in three regions of co-culture samples (p<0.05), which were of 1.47±0.28N, 
2.43±0.33N and 4.63±0.39N in chondrogenic, middle and osteogenic regions. There 
were no difference between regions in all control groups (p>0.05); the max loads in 
chondrogenic control, osteogenic control and cell-free scaffold control were: 
1.37±0.24, 4.63±0.43 and 0.66±0.08N. All groups were significantly higher than 
cell-free scaffold control (p<0.05). No significant difference was found between 
chondrogenic control and chondrogenic region group from co-cultured samples; 
similarly, no statistically significant difference was found between osteogenic control 




Fig. 6-13 Mechanical testing of BMSCs-seeded scaffolds after 2 weeks’ of co-culture. 
(A, B) Instron 3345 Tester system, sample was indicated by arrow. (C) Max 
compressive loads were compared among three regions of co-cultured samples and 





In this chapter, two steps of work have been done. In the first step, hypertrophic 
chondrogenic medium (HCM) has been proven that it was able to induce the 
differentiation of hypertrophic chondrocytes from BMSCs and cause mineralized 
ECM formation. In the second step, a three-chambered bioreactor was fabricated to 
supply chondrogenic, HCM and osteogenic stimulation mediums to a silk/peptide 
scaffold seeded with BMSCs. Results showed that layered structures were formed by 
using this bioreactor.  
 
6.4.1. Effectiveness of HCM for osteochondral interface generation by BMSCs 
The object of this study was to investigate the potential of using HCM on 
hypertrophic chondrogenic cellular differentiation. Rabbit bone marrow stromal cells 
(BMSCs) were cultured both in 2D culture well and a 3D scaffold to analyze the 
stimulatory function of HCM. Results from the present study confirmed that HCM 
had the potential to induce chondrogenic hypertrophic differentiation both in 2D and 
3D matrix. The genetic and histology results showed that BMSCs could differentiate 
into hypertrophic chondrocyte lineage under HCM in vitro and produced mineralized 
ECM with high amount of GAG.  
To investigate the stimulatory ability of HCM to induce stromal cells 
hypertrophic differentiation, gene expression analysis was used in this study both in 
2D and 3D model. Five gene markers were used in this study:  runt-related 
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transcription factor-2 (Runx-2), Type I Collagen (Col 1), Sox-9, Aggrecan (Agg) and 
Type X Collagen. Type X collagen is a special type of collagen and is one of the most 
important ECM constituents in this layer of the osteochondral intermediated region. 
Gene-expression data for 2D model showed that only BMSCs cultured in HCM 
expressed the Col X after two weeks culture. Sox-9 and Agg are considered as the 
common chondrogenic makers. In addition, reports also showed that when 
chondrocytes differentiate into mature hypertrophic chondrocytes, the expression of 
Sox-9 and Agg might decrease or even stop [218]. In the 2D model, under the effect 
of HCM, the expressions of these two genes in HCM group were lower than 
Chondrogenic control group by more than half. However, Sox-9 was still significantly 
higher than Osteogenic control. On the other hand, Col I expression in HCM group 
was half of that in Osteogenic control but still 2 folds higher than Chondrogenic 
control. Runx2 regulates osteoblast and chondrocyte maturation [219], this responsive 
to both chondrogenic and osteogenic signaling pathways[220, 221]. The highest 
expression of genes in HCM group suggested the maturation of chondrogenic 
differentiation under HCM culture. Results from 3D model show similar results.  All 
the above genetic results suggested that, under culture by HCM, the BMSCs could 
differentiate into hypertrophic chondrogenic cell lineage in 2 weeks.  
For the successful generation of osteochondral intermediated region, a lightly 
mineralized but GAG rich ECM is needed during the formation process [222, 223]. In 
the present study, Alizarin red staining showed that in 2D and 3D model, a high level 
of positive staining was observed in the Osteogenic control. A few red dots were 
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present in the samples exposed to the HCM, indicating a low level of calcium 
deposition in the ECM. However, in the Chondrogenic control, no calcium deposition 
was visible in both 2D and 3D. In contrast, after 2 weeks, a high level of staining in 
the cells exposed to Chondrogenic control and HCM in both models. This indicates a 
high level of GAG in the ECM, while no staining was observed in the Osteogenic 
control samples. These results indicated that under stimulation by HCM, BMSCs 
could produce mineralized ECM with high amount of GAG.  
The presence of TGF-β growth factors can lead to BMSCs chondrogenic 
differentiation and differentiated chondrocytes will deposit collagen type II [224]. 
TGF-beta delays hypertrophy and inhibit terminal differentiation [215]. However, on 
the other hand, β-glycerophosphate has been shown that it can induce the 
hypertrophic differentiation and mineralized ECM formation [203, 225]. In the 
present study, TGF-β3 and β-glycerophosphate were both used in HCM, which 
successfully induced the BMSCs hypertrophic differentiation, but had slower rate of 
ECM mineralization compared with osteogenic medium. The underlying mechanism 
is still unclear; thus, more studies should be done to find out the mechanism and the 
optimal concentration of these factors to better control the rate of hypertrophic 




6.4.2. Effectiveness of three-chambered bioreactor for osteochondral interface 
and multilayered osteochondral tissue formation 
Based on the first step of study in this chapter, HCM has been proved that to be 
able to induce the differentiation of hypertrophic chondrocytes and the formation of 
osteochondral interface. In the subsequent step, a three-chambered bioreactor that can 
provide chondrogenic, osteogenic mediums and HCM was fabricated. The aim was to 
induce the BMSCs located in different zones of silk/peptide scaffolds to differentiate 
into chondrocyte, hypertrophic chondrocyte and osteoblasts concurrently, hence 
forming the layered structure. Moreover, the automatic medium change ability 
effectively reduced the unwanted diffusion through different chambers and stably 
facilitated BMSC production/deposition of related ECM compositions and modulation 
of gene expression of various marker genes in multilayered osteochondral constructs. 
The interface-specific genes suggested the differentiation of the middle region’s 
BMSCs into hypertrophic chondrocyte phenotype. Moreover, multilayered 
osteochondral constructs were also successfully generated by this co-culture system. 
The results showed that the BMSCs in different zones of the scaffold committed 
to differentiation in different pathways. The quantitative RT-PCR results confirmed 
the differentiation. In our study, chondrogenic, hypertrophic chondrogenic and 
osteogenic differentiation was induced by three types of medium supplying in the 
three regions of the scaffold. Results showed that this kind of co-culture system have 
the potential to induce the BMSCs hypertrophic differentiation in the middle region. 
In addition, the different mediums in three regions could further improve layered 
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ECM formation, which was confirmed by results from first step of this chapter. In 
addition, result from Chapter 4 and Chapter 5 also showed that cell-cell interaction 
could also contribute to the formation of hypertrophic chondrocytes and 
osteochondral interface.  
When compared with osteogenic control, all gene expressions in osteogenic 
region were not significantly different. Similarly, when comparing with chondrogenic 
control, all gene expression in chondrogenic region was similar, except the 
chondrogenic control have higher Aggrecan expression. Hypertrophic chondrocytes 
are the main cell type in the osteochondral interface region and have a larger size than 
normal chondrocytes [29, 62]. By comparing with control groups and different 
regions from co-culture sample, the results demonstrated that the co-culture bioreactor 
can truly introduce the differentiation of BMSCs into chondrogenic, osteogenic and 
hypertrophic chondrogenic cell lineage simultaneously. This was also supported by 
the results of H&E staining. Different cell morphologies could be observed in the 
three regions. Although cells in both the middle region and the chondrogenic region 
were of spherical morphology, larger cell size could be found in the middle region. By 
comparing with RT-PCR results in static two-chambered system, the gene expression 
results here showed that all chondrogenic and osteogenic related gene markers 
between chondrogenic region and osteogenic were significantly different by using the 
three-chambered bioreactor.  
Besides the different cells, osteochondral tissue is multilayered in ECM [12, 207, 
226].  As mentioned in Chapter 5, the osteochondral interface has a transitional 
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ECM, which included GAG and different type of Collagen. Moreover, it is a 
mineralized ECM [195, 209]. In this step of work, results from histological 
examination suggested that layered distribution of GAG and calcium in ECM could 
be observed in co-culture samples; however, the layered boundary was not very 
obvious. In the chondrogenic region and chondrogenic control, cells with spherical 
morphology chondrocyte were embedded in a GAG-rich and un-mineralized ECM. In 
contrast, in the osteogenic region and osteogenic control, cells with star-shaped 
morphology like osteoblasts were embedded in a mineralized ECM with high density 
of calcium. However, a GAG rich and mineralized ECM could be found in middle 
region. In addition, the SEM analyses also confirmed this finding. Thus, besides the 
different gene expression, this co-culture system could also generate a multilayered 
ECM structure that better mimicked the native osteochondral tissue and has much 
better layered stimulation ability than static two chambered wells.  
Due to the different compositions of ECM, each zone of osteochondral tissue 
contains significantly different mechanical properties [1, 69]. In this step of work, 
compressing test has been done; the results showed that after two weeks’ co-culture, 





6.5. Concluding remarks  
A three-chambered bioreactor was designed to provide chondrogenic, osteogenic 
and HCM concurrently for osteochondral multilayered tissue regeneration in vitro. 
The automatic medium change function reduces the unwanted diffusion effectively, 
which facilitated better layered structure formation. Results in this study demonstrated 
that this three-chambered bioreactor could successfully provide stimulation to rabbit 
BMSCs in different zones of the scaffold, resulting in the formation of multilayered 
osteochondral constructs with cartilage, subchondral bone tissue, as well as the 
osteochondral interface in 2 weeks culture in vitro. Cells in the intermediate region 
could be differentiated into hypertrophic chondrocytes, which were embedded in a 
calcified ECM with rich glycosaminoglycans, Collagen Type I, II and X. Above all, 
the results of this study provided another possible one-step approach in supporting the 
choice of BMSCs as a single cell source for multilayered osteochondral construct 





Chapter 7  
 
Conclusions and Recommendations 
 
7.1. Conclusions 
Novel co-culture methods of osteochondral interface and multilayered 
osteochondral construct generation were developed in this project. In the initial 
material assessments, it was shown that the silk microsponge and peptide nanofiber 
mesh scaffold could provide a porous and hydrogel-based structure that was suitable 
for cartilage and bone regeneration. Compared to the control (microfiber-reinforced 
sponge scaffold), BMSC-seeded silk/RADA scaffolds showed enhanced cell 
proliferation, increasing amounts of total collagen and GAGs. 
In the first co-culture system, results revealed that specific spatially controlled 
regulation from osteoblasts in the 2D-3D co-culture system could help to introduce 
hypertrophic differentiation of chondrogenic rBMSCs on the scaffold and improve the 
calcified cartilage-like ECM formation in the scaffold. Based on the results from the 
2D-3D interface co-culture system, it was demonstrated that this system has the 
potential to induce the formation of the osteochondral interface in vitro (hypothesis 1). 
However, beside the interface and cartilage layer, the osteochondral tissue has bone 
layer. Thus, the way to generate a three layered constructs, included cartilage, 
interface and bone is necessary. Subsequently, in 3D-3D co-culture system, 
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pre-chondrogenic/pre-osteogenic BMSCs co-culture system also demonstrated that it 
had the potential to induce chondrogenic hypertrophy. Furthermore, beside interface 
generation, this system provided a new method of fabricating a multilayered 
osteochondral construct by using only one type of cell sources--BMSCs and 
SF/RADA scaffold. A cartilage-like zone that is full of GAG and Collagen II and a 
subchondral bone-like zone with mineralized ECM enriched with Collagen I and an 
osteochondral interface in the intermediate region could be generated concurrently by 
using this system (hypothesis 2). 
In 3D-3D co-culture system, pre-differentiated culture step is required. 
Moreover, after 2 weeks co-culture, a gap between two pieces can still be observed. 
To simplify the culture step and solve the fusion problems, a one step co-culture 
method will be helpful. In Cheng’s work, pre-differentiated BMSCs/polymer scaffold 
was adhered by BMSCs/microsphere, two pieces were fused better [126]. However, 
pre-differentiated step is still needed. 
 A novel co-culture well was designed for a single cell source for multilayered 
osteochondral construct regeneration without pre-differentiation process in vitro. The 
model developed in this project provides another possible method for further 
treatment and idea for other types of multilayered tissue generation. It was shown that 
the co-culture well allowed chondrogenic and osteogenic stimulated factors to induce 
BMSCs in different zones of the scaffold to differentiate into chondrocytes, 
hypertrophic chondrocytes and osteoblasts lineage, thus supporting the possibilities of 
regenerating the whole osteochondral constructs with interface (hypothesis 3). By 
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compared with other studies, the most important advantage of this co-culture system 
is to generate osteochondral multilayered tissue by one step in a single scaffold.  
To reduce the unwanted medium diffusion, a three-chamber bioreactor was 
designed and fabricated in this project. This three-chamber bioreactor with the ability 
to automatically change medium was designed to provide chondrogenic, osteogenic 
and HCM concurrently for osteochondral multilayered tissue regeneration in vitro, 
facilitating the formation of a better layered structure. The result of the three-chamber 
co-culture system provided another possible one-step approach in supporting the 
choice of BMSCs as a single cell source for multilayered osteochondral construct 
regeneration without pre-differentiated process in vitro (hypothesis 4). 
     In summary, 2D-3D co-culture system proves the possibility to use BMSCs 
generate the multilayered constructs, included cartilage layer and interface. However, 
another important layer—subchondral bone layer is still absence. To solve this issue, 
3D-3D co-culture system was designed and successfully generated three layered 
tissue. To further simply the pre-differentiated step and better provide stimulation 
environment, a two-chambered system that provides two types of medium was used. 
Multilayered osteochondral tissue was successful regenerated by this one step 
co-culture system. By using this co-culture well, some unwanted medium diffusion 
was found between chambers. To solve this problem, a three-chambered bioreactor 
that can change mediums automatically was design to control the diffusion. Results 
showed that the arrangement of layered tissue is better than two-chamber well.   
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7.2. Recommendations and future work 
In the whole project, several co-culture models were introduced.  By using this 
direct contact model, chondrogenic BMSCs has been shown to have the potential to 
generate the osteochondral interface. However, the mechanism was still unclear; the 
key factors of stimulation should be further investigated in future studies, such as the 
growth factors produced by osteoblasts or osteogenic BMSCs, cell-cell direct contact 
stimulations. To better understand the mechanism, different co-culture models, such 
as the direct contact model, indirect model that only allows the medium exchange 
between different types of cells [1], might also be considered. Limitations in the 
current scientific knowledge about specific cellular markers for BMSCs, osteoblasts, 
chondrocytes and hypertrophic chondrocytes in the New Zealand White Rabbit 
species made it challenging to investigate the differentiation of BMSCs. In this study, 
only some of the most commonly used gene markers or ECM compositions could be 
used to show the different lineage differentiation. Thus, in future work, human 
BMSCs could be used to overcome this issue, as a multitude of specific markers could 
be used. For instance, more gene markers and portions will provide much wider 
choices and stronger demonstration, which are presently not known in rabbits. 
Moreover, human cells may have different differentiation duration and response. Thus, 
the use of human cells will make it possible to investigate the optimized scaffold 
design, co-culture strategies, culture period and dosage of growth factors.   
In the studies of co-culture well and bioreactor, there is some concern regarding 
the applicability of diffusion analysis to all the stimulatory components in the system. 
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Although the medium diffusion across the whole scaffold has been shown by 
Alamarblue staining and FITC-BSA, stimulation factors, such as TGF-beta3 and 
beta-glycerophosphate all have different molecular weights and, likely, diffusion 
properties. Thus, some detailed assessment that can track these factors may provide 
more useful information that plays a critical role in the validation of the co-culture 
chambers. 
    The aim of tissue engineering is to translate the experimental findings to clinical 
applications, thus a successful preclinical animal study is an important prerequisite. 
Though the in vitro studies in the current project provided significant information 
about the osteochondral multilayered tissues and interface formation, experimental 
testing in appropriate animal models are necessary for further evaluation and 
optimization. New Zealand White Rabbits will be used as test models. After 2 weeks 
co-culture, the engineered osteochondral plugs from co-culture models will be 
implanted into the knee osteochondral defects and try to treat the defects. Briefly, 
under anaesthesia condition, the knee joint was opened with a medial parapatellar 
approach. A full-thickness cylindrical cartilage defect that reaches the bone region 
will be created in the patellar groove of the bilateral knees using a stainless-steel 
punch. On the experimental side, the co-cultured grafts will be plant in the defects 
directed toward the subchondral bone. In the other knee, the defect will be covered by 
drafts seeded with BMSCs as control. In the post-operative assessments, the 
regeneration of the whole cartilage-bone at tissue-engineered osteochondral graft will 
be tested. This study could prove that BMSC-seeded samples that are pre-cultured by 
 141 
 
these co-culture systems will result in better and faster healing layered osteochondral 
defects. Subsequently, load-bearing animal models are preferred in the second step of 
animal works, such as pig models, which can be used to investigate the healing ability 
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B-1. Design of two-chambered co-culture well 
 
Co-culture plate with dimensions 150mm x 100mm x 20mm (depth) were 
designed (Figure B-1 – B-2) and fabricated from transparent Polycarbonate blocks. 
Each plate contains 8 wells. At the same time, Polycarbonate septum of dimensions 
14mm x 10mm x 2mm with a 2mm radius hole in the middle (Figure B-4) and 
Polycarbonate lids of dimensions 150mm x 100mm x 5mm (Figure B-3) were made. 
Septum was cemented to the groove in the well of the plate using silicone.  
 





Fig. B-2 Section view of co-culture plate (without septum) 
 































B-2. Design of three-chambered co-culture well  
 
This three-chambered well was assembled by 4 parts: main part with dimensions 
28mm x 60mm x 20mm were designed (Figure B-5) and fabricated from transparent 
Polycarbonate blocks. Each main part was covered by two pieces of side covers: 5mm 
x 60mm x 2mm with a groove in middle for O’ring (Figure B-6) and Polycarbonate 
cover of dimensions 64mm x 4mm x 2mm (Figure B-7) were made.  
 
 







































Fig. B-7 Design of top cover. 
 
